Document:

Employment Agreement

 EXHIBIT 10.1 
  
 EMPLOYMENT AGREEMENT BETWEEN 
 PETCO ANIMAL SUPPLIES, INC. AND DAVID BOLEN 
  
 This EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of January 23, 2006 (the “Effective Date”) by and between PETCO Animal Supplies, Inc., a Delaware corporation (“PETCO” or “the
Company”) and David Bolen (“Executive”). PETCO and Executive are hereinafter collectively referred to as the “Parties,” and are individually referred to as a “Party.” 
  
 RECITALS 
  
 A. PETCO desires to assure the association and services of Executive in order to retain Executive’s experience, skills, abilities,
background and knowledge, and is willing to engage Executive’s services on the terms and conditions set forth in this Agreement. 
  
 B. Executive desires to be employed by PETCO, and is willing to accept such employment on the terms and conditions set forth in this Agreement. 
  
 AGREEMENT 
  
 Now, THEREFORE, in consideration of the foregoing Recitals and the mutual promises and covenants herein contained, and for
other good and valuable consideration, the Parties, intending to be legally bound, agree as follows: 
  

	1.	EMPLOYMENT. 

  

	1.1	PETCO hereby employs Executive, and Executive hereby accepts employment by PETCO, upon the terms and conditions set forth in this Agreement, for the period commencing on
January 23, 2006 and ending as provided in paragraph 4 hereof (the “Employment Period”). 

  

	1.2	Executive shall serve as Executive Vice President, Chief Merchandising Officer of the Company and shall report to the Chief Executive Officer of PETCO, initially having
responsibility over merchandising, marketing or any other duties delegated to him by the CEO. 

  

	1.3	Executive shall do and perform all services, acts or things necessary or advisable to manage and conduct the business of the Company, consistent with the bylaws of the Company and
as required by the Company’s Board of Directors (“Board”) or Chief Executive Officer (“CEO”), and which are customarily associated with the position of his position as Chief Merchandising Officer. 

 

	1.4	 Unless the Parties otherwise agree in writing, during the term of this Agreement, Executive shall perform his services at PETCO’s offices, located in San
Diego, California or such other facilities of the Company as 

	 	 
the Company and Executive may agree upon from time to time; provided, however, that the Company may from time to time require Executive to travel temporarily
to other locations in connection with the Company’s business. 

  

	2.	LOYAL AND CONSCIENTIOUS PERFORMANCE; NONCOMPETITION. 

  

	2.1	During the Employment Period, Executive shall devote his full business energies, interest, abilities and productive time to PETCO. This paragraph shall not preclude Executive from
engaging in civic, charitable or religious activities, or from serving on boards of directors of companies or organizations that do not present any conflict with the interests of the Company or otherwise adversely affect the Executive’s
performance of his duties. 

  

	2.2	Except with the prior written consent of the Board, Executive will not, during the Employment Period, or any period during which Executive is receiving compensation or any other
consideration from the Company, including any payments pursuant to Section 4 herein, compete with the Company, either directly or indirectly, in any manner or capacity, as adviser, consultant, principal, agent, partner, officer, director,
employee, member of any association or otherwise, in any phase of developing, manufacturing or marketing any product or service that is in the same field of use or that otherwise competes with a product or service that is offered, is actively under
development, or is actively being considered for development by the Company. 

  

	2.3	Except as permitted herein, Executive agrees not to acquire, assume or participate in, directly or indirectly, any position, investment or interest that Executive knows or should
know is adverse or antagonistic to the Company, its business, clients, strategic partners, investors or prospects. Ownership by Executive, as a passive investment, of less than five percent (5%) of the outstanding shares of capital stock of any
corporation with one or more classes of its capital stock listed on a national securities exchange or publicly traded in the over-the-counter market shall not constitute a breach of this paragraph. 

  

	3.	COMPENSATION AND BENEFITS. 

  

	3.1	The Company will pay Executive a Base Salary of Five Hundred Thousand Dollars ($500,000) per year in bi-weekly installments of $19,230.76. Such salary shall be prorated for any
partial year of employment on the basis of a 365 day fiscal year. 

  

	3.2	 Executive’s Base Salary shall be reviewed annually and adjusted in the Company’s sole discretion. Executive will be eligible to participate in the annual
salary administration process in April 2007. Executive’s 

  

 2 

	 	 
performance will be reviewed and an increase may be granted for the fiscal year 2006 based on satisfactory or above performance.

  

	3.3	All of Executive’s compensation shall be subject to customary withholding taxes and any other employment taxes as are commonly required to be collected or withheld by the
Company. 

  

	3.4	Annual Performance Bonus - At the discretion of the Board of Directors, the Company will target a bonus payment for fiscal year 2006, based on eighty percent (80%) of
Executive’s annual base salary (for the period January 29, 2006 through January 28, 2007, payable in March 2007.) Seventy five percent (75%) or $300,000 of the fiscal year 2006 target bonus will be paid upon presentation of
evidence of Executive’s contract to purchase a home in San Diego County. Should Executive’s employment terminate, for any reason, prior to March 2007, Executive agrees to repay the full amount of any portion of the fiscal year 2006 target
bonus that he has been paid. Subsequent bonus payments, if approved by the Board of Directors, are typically awarded in March. Executive must be employed at PETCO at the time the bonus is paid in order to be eligible to receive the payment.

  

	3.5	During the Employment Period, the Company agrees to reimburse Executive for all reasonable and necessary business expenses subject to the Company’s standard requirements
regarding the reporting and documentation of such expenses. 

  

	3.6	Executive shall, in accordance with Company policy and the terms of the applicable plan documents, be eligible to participate in the PETCO group medical, dental and vision plans
upon hire. Executive will also be provided financial, investment, estate and tax planning services from AYCO Financial Services as a part of the Executive’s benefit package. These benefits are provided at no cost to the Executive. The Company
may modify or cancel its benefit plan(s) in its discretion, consistent with the requirements of state or federal law. 

  

	3.7	Disability and Life Insurance - Executive will be eligible for short-term and long-term disability insurance and Company-paid Group Term Life Insurance equal to three times his
annual earnings up to a maximum of $1,000,000.00 and AD&D Insurance upon hire. These benefits are provided at no cost to Executive. 

  

	3.8	401(k) Savings Plan - Executive will be eligible to participate in the Company sponsored 401(k) plan effective the first of the month following Executive’s one-year anniversary
with the Company, provided that Executive meets all eligibility requirements. Executive may elect to contribute up to twenty (20) percent of his salary on a tax-deferred basis. PETCO will provide a matching fifty (50) percent contribution
on the first three percent of Executive’s deferred salary contribution. 

  

 3 

	3.9	Executive shall, in accordance with Company policy, be entitled to receive twenty (20) days of Paid Time Off (PTO) upon the beginning of employment and an additional twenty
(20) days on the one-year anniversary of employment and each anniversary thereafter. PTO must be taken according to the terms of PETCO’s policy. Executive shall not accrue more than eight weeks of PTO, and shall use such PTO in a manner
that is minimally disruptive to Company’s business. 

  

	3.10	Non-Qualified Deferred Compensation Plan - Executive may contribute up to seventy-five percent of his base pay and up to one hundred percent of his bonus pay each calendar year into
the non-qualified deferred compensation plan upon hire. PETCO has a discretionary match of $.50 on each dollar up to a maximum of three percent of an employee’s contribution for base pay and $.50 on each dollar up to a maximum of six percent of
an employee’s contribution for bonus pay. Executive may enroll in the Plan within thirty days of hire and each year in December for the following year. 

  

	3.11	Subject to the Board’s approval, PETCO will grant Executive one hundred fifty thousand (150,000) stock options upon hire. All stock option grants are issued according to
the terms of PETCO’s Stock Option Plan and are subject to approval by the Board of Directors. Options normally are granted annually in March under the plan. Executive’s initial options will vest one-half upon the first anniversary of hire,
and one-half on the second anniversary. All future equity incentives will be a combination of stock options and restricted stock units, which will vest according to the terms of their agreements. 

  

	3.12	Executive shall receive, subject to all IRS requirements, a leased automobile commensurate with the Lexus LS 430 with accompanying insurance and gasoline card. This automobile lease
use shall cease upon (i) Executive’s providing the Company of notice of his resignation; or (ii) the Company providing Executive notice of his termination. 

  

	3.13	PETCO Discount and Other Benefits - Executive will be eligible to participate in a number of PETCO-sponsored benefits including a twenty percent (20%) merchandise discount at
all PETCO stores. Additionally, as a PETCO employee, Executive will receive discounted pet insurance through PetCare Pet Insurance, membership privileges at the San Diego County Credit Union, a discount at 24-Hour Fitness Centers, and discounted
childcare at Children’s World Learning Centers. These benefits are effective upon hire. 

  

	3.14	 Relocation Expenses - PETCO’s relocation policy requires that Executive execute a Repayment Agreement before the Company will assist with any relocation costs.
This Repayment Agreement states that Executive will repay the Company a prorated portion of all relocation expenses if Executive leaves the employment of PETCO voluntarily or for cause prior 

  

 4 

	 	 
to completing two years of service. A copy of the Repayment Agreement is attached hereto as Exhibit C. Subject to Executive’s execution of the Repayment
Agreement, PETCO will provide Executive with the following relocation assistance to San Diego (all relocation expense reimbursements will be grossed up): 

  
 (1) Reimbursement for the cost of packing and moving Executive’s household goods to the San Diego area through the use
of PETCO’s preferred carrier. 
  
 (2) Reimbursement for
reasonable house-hunting trips prior to Executive’s move to San Diego inclusive of airfare, lodging, daily meal allowance and car rental. Travel arrangements will be made through PETCO’s on-site travel agent and Talent Acquisition
Department. 
  
 (3) Reimbursement for normal and reasonable
commissions and other usual and customary costs associated with the sale of Executive’s primary residence in Ohio and usual and customary closing costs associated with a new home purchase in San Diego. PETCO will not reimburse pre-paid
interest, underwriting fees used to buy down interest rates or any recurring real estate costs as part of Executive’s relocation package. 
  
 (4) Reimbursement for the cost of temporary housing through June 15, 2006, if necessary for Executive prior to purchase of a home in San Diego.
Temporary housing will be arranged through PETCO’s Talent Acquisition Department. 
  
 (5) A discretionary allowance of Five Thousand Dollars ($5,000) to be used for any incidental expenses during Executive’s move to San Diego. 
  

	4.	TERM. 

  
 PETCO is an “at will” employer and as such, employment with PETCO is not for a fixed term or definite period and may be terminated at the will
of either party, with or without cause, and without prior notice. No supervisor or other representative of the company (except PETCO’s CEO) has the authority to enter into any agreement for employment for any specified period of time, or to
make any agreement contrary to the above. This is the final and complete agreement on this term. Any contrary representations which may have been made or which may be made to Executive are superseded by this Agreement. 
  

	(a)	If the Employment Period is terminated by the Company, or by Executive’s resignation, or as a result of Executive’s death or permanent disability, Executive shall be
entitled to receive his Base Salary through his termination date plus any accrued but unused vacation. 

  

	(b)	 Notwithstanding the at-will nature of the employment relationship between PETCO and Executive, if Executive’s employment is terminated by 

  

 5 

	 	 
PETCO without Cause and explicitly conditioned upon Executive’s furnishing to the Company an executed waiver and release of claims (in substantially the
form of Exhibit A, which is attached to this Agreement), Executive shall be entitled to receive: 

  

	 	(i)	A lump sum payment equal to 18 months of his current base salary in effect as of the date of termination, subject to standard deductions and withholdings, payable within twenty
(20) days after the date of termination; and 

  

	 	(ii)	Continued medical benefits for a period of 18 months, to the extent permitted under COBRA. 

  

	(c)	For purposes of this Agreement, “Cause” shall mean: 

  

	 	(i)	Any act that, in the discretion of the Board, is materially contrary to the best interests of the Company; 

  

	 	(ii)	The failure or refusal by Executive to perform his duties hereunder that has not been remedied within ten (10) business days after written demand for substantial performance
has been delivered to Executive by the Company, which demand identifies the manner in which Company believes that the Executive has not performed such duties and the steps required to cure such failure to perform; 

  

	 	(iii)	The conviction of Executive of, or the entering of a plea of nolo contendere by Executive with respect to a felony; or 

  

	 	(iv)	Executive’s drug or alcohol addiction. 

  

	(d)	Executive will also be entitled to the severance benefits in Section 4(b) above, should Executive terminate his employment for Good Reason, and explicitly conditioned upon
Executive’s furnishing the Company an executed waiver and release of claims (in substantially the form of Exhibit A, which is attached to this Agreement). 

  
 For purposes of this Agreement, “Good Reason” shall mean: 
  

	 	(i)	A reduction or adverse change, without the express written consent of Executive, in Executive’s duties, authority, functions, title or status as provided herein;

  

	 	(ii)	PETCO’s failure to pay Executive’s base salary or any failure to pay Executive compensation or benefits to which he is entitled, which is not cured within five
(5) business days of the written notice of such breach to the Company; 

  

	 	(iii)	 PETCO’s requiring Executive to relocate to a place outside a fifty (50) mile radius of its present location in San Diego, California, 

  

 6 

	 	 
excluding reasonably required travel on the Company’s business that is not materially greater than travel generally required for Executive’s
position; 

  

	 	(iv)	A material breach of any provision of this Agreement by the Company; or 

  

	 	(v)	The failure of the Company to obtain the assumption in writing of its obligation to perform this Agreement by any successor to all or substantially all of the assets of the Company
(a “Change in Control” as defined below) within 60 days after a merger, consolidation, sale or similar transaction, unless assumption occurs by operation of law. 

  
 A “Change in Control” shall be deemed to occur: 
  
 (a) if any person or entity (or related group of persons or entities) other than persons or entities owning more than five
percent of the Company’s outstanding securities as of the effective date of the Agreement is or becomes the “beneficial owner” (within the meaning of Rule 13d 3 under the Exchange Act), directly or indirectly, of securities of the
Company representing 50% or more of the combined voting power of the Company’s then outstanding securities; 
  
 (b) upon the consummation of a Transaction which was previously approved by the Company’s stockholders; or 
  
 (c) if, during the term of the Plan, members of the Incumbent Board cease
for any reason to constitute at least a majority of the Board. 
  
 Notwithstanding the foregoing, a Change in Control pursuant to subparagraphs (b) and (c) above shall not be deemed to occur if immediately following the consummation of a Transaction or other event approved by the incumbent Board,
holders of the Company’s voting securities immediately prior to a Transaction either continue to own at least 50% of the combined voting power of the Company’s then outstanding voting securities if the Company survives the Transaction or
then own voting securities representing at least 50% of the combined voting power of each surviving entity after a Transaction. 
  

 7 

 For the purposes of this Section 4(d), a “Transaction” means a merger, consolidation or reorganization, a
distribution of the Company’s assets to the stockholders of the Company by spin-off, split-up or otherwise, a sale or disposition of all or substantially all of the Company’s assets or a liquidation or dissolution of the Company. In
addition to the benefits in Section 4(b) above, in the event of a Change in Control, all of Executive’s unvested stock options in the Company shall immediately vest, which shall be exercisable within 90 days. For termination based on a
Change in Control only, Executive shall also be entitled to receive an annualized bonus percentage payable at the time of termination. 
  

	5.	AMENDMENT AND WAIVER. 

  

	5.1	The provisions of this Agreement may be amended or waived only with the prior written consent of the Company and Executive, and no course of conduct or failure or delay in enforcing
the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement. 

  

	6.	CONFIDENTIAL AND PROPRIETARY INFORMATION; NONSOLICITATION. 

  

	6.1	Executive agrees to execute and abide by the Proprietary Information and Inventions Agreement attached and amended hereto as Exhibit B. 

  

	6.2	Executive recognizes that his employment with the Company will involve contact with information of substantial value to the Company, which is not generally known in the trade, and
which gives the Company an advantage over its competitors who do not know or use it, including but not limited to, techniques, designs, drawings, processes, inventions, developments, equipment, prototypes, sales and customer information, and
business and financial information relating to the business, products, practices and techniques of the Company, (hereinafter referred to as “Confidential and Proprietary Information”). Executive will at all times regard and preserve as
confidential such Confidential and Proprietary Information obtained by Executive from whatever source and will not, either during his employment with the Company or thereafter, publish or disclose any part of such Confidential and Proprietary
Information in any manner at any time, or use any Confidential and Proprietary Information except on behalf of the Company, without the prior written consent of the Company. 

  

	6.3	 While employed by the Company and for one (1) year thereafter, the Executive agrees that in order to protect the Company’s Confidential and Proprietary
Information from unauthorized use, that Executive will not, either directly or through others, solicit or attempt to solicit: (i) any employee, consultant or independent contractor of the Company to terminate his or her relationship with the
Company in order to become an employee, consultant or independent contractor to or for any other person or business entity; or (ii) the business of any customer, vendor or distributor, partner or strategic alliance of the Company which, at the
time 

  

 8 

	 	 
of termination or one (1) year immediately prior thereto, was doing business with the Company. 

  

	7.	ASSIGNMENT AND BINDING EFFECT. 

  
 This Agreement shall be binding upon and inure to the benefit of Executive and Executive’s heirs, executors, personal representatives, assigns,
administrators and legal representatives. Due to the unique and personal nature of Executive’s duties under this Agreement, neither this Agreement nor any rights or obligations under this Agreement shall be assignable by Executive. This
Agreement shall be binding upon and inure to the benefit of the Company and its successors, assigns and legal representatives. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken
place. 
  

	8.	NOTICES. 

  

	8.1	All notices or demands of any kind required or permitted to be given by the Company or Executive under this Agreement shall be given in writing and shall be personally delivered
(and receipted for) or mailed by certified mail, return receipt requested, postage prepaid, addressed as follows: 

  
 If to the Company: PETCO Animal Supplies, Inc., 9125 Rehco Road, San Diego, California 92121, Attn: Chairman of the Board of Directors 

 
 with a copy to: 
  
 Leonid M. Zilberman, Wilson Petty Kosmo & Turner
LLP, 550 West C Street, Suite 1050, San Diego, CA 92101 
  
 If to Executive: David Bolen, 7592 Yennicook Way, Hudson, OH 44236 
  
 Any such written notice shall be deemed received when personally delivered or three (3) days after its deposit in the United States mail as specified above. Either Party may change its address for notices by
giving notice to the other Party in the manner specified in this section. 
  

 9 

	9.	CHOICE OF LAW. 

  
 This Agreement is made in San Diego, California. The parties agree that it shall be construed and interpreted in accordance with the laws of the State of
California. 
  

	10.	INTEGRATION. 

  
 This Agreement contains the complete, final and exclusive agreement of the Parties relating to the subject matter of this Agreement, and supersedes all
prior oral and written employment agreements or arrangements between the Parties unless otherwise expressly referenced above. 
  

	11.	AMENDMENT. 

  
 This Agreement cannot be amended or modified except by a written agreement signed by Executive and the CEO. 
  

	12.	WAIVER. 

  
 No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived, except with the written consent of the Party against whom
the wavier in claimed, and any waiver or any such term, covenant, condition or breach shall not be deemed to be a waiver of any preceding or succeeding breach of the same or any other term, covenant, condition or breach. 
  

	13.	SEVERABILITY. 

  
 The finding by a court or arbitrator of the unenforceability, invalidity or illegality of any provision of this Agreement shall not render any other
provision of this Agreement unenforceable, invalid or illegal. Such court shall have the authority to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision that will most accurately represent
the parties’ intention with respect to the invalid or unenforceable term or provision. 
  

	14.	INTERPRETATION; CONSTRUCTION. 

  
 The headings set forth in this Agreement are for convenience of reference only and shall not be used in interpreting this Agreement. This Agreement has
been drafted by legal counsel representing the Company, but Executive has been encouraged, and has consulted with, his own independent counsel with respect to the terms of this Agreement. The Parties acknowledge that each Party and its counsel has
reviewed and revised, or had an opportunity to review and revise, this Agreement, and the normal rule of construction to the effect that any 

  

 10 

 
ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. 
  

	15.	REPRESENTATIONS AND WARRANTIES. 

  
 Executive represents and warrants that he is not restricted or prohibited, contractually or otherwise, from entering into and performing each of the terms
and covenants contained in this Agreement, and that his execution and performance of this Agreement will not violate or breach any other agreements between Executive and any other person or entity. 
  

	16.	ARBITRATION. 

  

	16.1	The Parties agree to arbitrate any dispute, claim, or controversy (“Claim”) including, but not limited to, claims of employment discrimination and harassment under Title
VII of the Civil Rights Act, as amended, and the California Fair Employment & Housing Act, age discrimination under the Age Discrimination in Employment Act, as amended, the Americans with Disabilities Act, 42 U.S.C. section 1981, the
Employment Retirement Income Security Act, the California Labor Code, breach of employment contract or the implied covenant of good faith and fair dealing, wrongful discharge, or tortious conduct (whether intentional or negligent) including
defamation, misrepresentation, fraud, infliction of emotional distress, but excluding claims for workers’ compensation benefits or claims for wages before the California Department of Industrial Relations. 

  

	16.2	The arbitration shall be conducted by a single neutral arbitrator in accordance with the rules issued by the American Arbitration Association (“AAA”) for resolution of
employment disputes. The arbitration shall take place in the City of San Diego. The Company will pay the fee for the arbitration proceeding, as well as any other charges by the AAA. 

  

	16.3	The Arbitrator shall issue a written decision or award. The decision or award of the arbitrator shall be final and binding upon the Parties. The arbitrator shall have the power to
award any type of relief that would be available in a court of competent jurisdiction. Any award may thereafter be entered as a judgment in any court of competent jurisdiction. Executive agrees that any relief to which he is entitled arising out of
his employment or cessation of that employment shall be limited to that awarded by the arbitrator. 

  

	16.4	Executive agrees to file any demand for arbitration within the time limit established by the applicable statute of limitations for the asserted claims. Failure to demand arbitration
within the prescribed time period shall result in waiver of any claims. 

  

	16.5	 A court construing this Agreement may modify, or interpret it to the extent and such manner as to render it enforceable. If this Agreement is declared unenforceable
and cannot be administered, interpreted, or 

  

 11 

	 	 
modified to be enforceable, Executive agrees to waive any right he may have to a jury trial with respect to any dispute or claim against the Company relating
to his employment, his termination from employment, or any terms and conditions of his employment with the Company. 

  

	16.6	Executive has agreed to this arbitration provision in consideration of his employment by the Company and upon consultation with private counsel. 

  

	17.	LITIGATION COSTS. 

  
 Should any litigation, arbitration, or administrative action be commenced between the Parties or their personal representatives concerning any provision
of this Agreement or the rights and duties of any person in relation to this Agreement, the Party or Parties prevailing in such action shall be entitled, in addition to such other relief as may be granted, to a reasonable sum for that Party’s
attorney’s fees, which shall be determined by the court, arbitrator, or administrative agency. 
  

	18.	TRADE SECRETS OF OTHERS. 

  
 It is the understanding of both the Company and Executive that Executive shall not divulge to the Company and/or its subsidiaries any confidential
information or trade secrets belonging to others, including Executive’s former employers, nor shall the Company and/or its affiliates seek to elicit from Executive any such information. Consistent with the foregoing, Executive shall not provide
to the Company and/or its affiliates, and the Company and/or its affiliates shall not request, any documents or copies of documents containing such information. 
  

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written. 
  

					
			
	  	 	 	 	  
	 David Bolen
	 	 	 	 James Myers, CEO

	 	 	 	 	 PETCO Animal Supplies, Inc.

  

 12 

 EXHIBIT A 
  

RELEASE AND WAIVER OF CLAIMS 
  
 In consideration of the payments and other benefits set forth in Section 4 of the Employment Agreement dated January 23, 2006 to which this form
is attached, I, David Bolen (“Executive”), hereby furnish PETCO Animal Supplies, INC. (the “Company”), with the following release and waiver (“Release and Waiver”). 
  
 I hereby release, and forever discharge the Company, its officers, directors,
agents, employees, stockholders, successors, assigns, affiliates and benefit plans, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and
nature, in law, equity, or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed, arising at any time prior to and including my employment termination date with respect to any claims relating to my employment or the
termination of my employment, including but not limited to claims pursuant to any federal, state or local law relating to employment, such as discrimination claims under the California Fair Employment and Housing Act, the Federal Age Discrimination
in Employment Act of 1967, as amended (“ADEA”), or Title VII of the Civil Rights Act of 1964, or claims for wrongful termination, breach of the covenant of good faith and fair dealing, contract claims, tort claims, and wage or benefit
claims, including but not limited to, claims for salary, bonuses, commissions, stock, stock options, vacation pay, fringe benefits, severance pay or any form of compensation. 
  
 In releasing claims unknown to me at present, I am waiving all rights and benefits under Section 1542 of the California
Civil Code, and any law or legal principle of similar effect in any jurisdiction: 
  
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE
DEBTOR.” 
  
 I acknowledge that, among other rights, I am
waiving and releasing any rights I may have under ADEA, that this release and waiver is knowing and voluntary, and that the consideration given for this release and waiver is in addition to anything of value to which I was already entitled as an
Executive of the Company. 
  
 I further acknowledge that I have
been advised, as required by the Older Workers Benefit Protection Act, that: (a) the release and waiver granted herein does not relate to claims which may arise after this release and waiver is executed; (b) I have the right to consult
with an attorney prior to executing this release and waiver (although I may choose voluntarily not to do so); and if I am over 40 years old upon execution of this (c) I have twenty-one (21) days from the 

  

 13 

 
date of termination of my employment with the Company in which to consider this release and waiver (although I may choose voluntarily to execute this release
and waiver earlier); (d) I have seven (7) days following the execution of this release and waiver to revoke my consent to this release and waiver; and (e) this release and waiver shall not be effective until the seven (7) day
revocation period has expired. 
  

							
				
	 Date:
	 	  	 	 	 	  
	 	 	 	 	 	 	 EXECUTIVE

  

 14 

 EXHIBIT B 
  

PETCO EMPLOYEE PROPRIETARY INFORMATION 
  
 AND INVENTIONS AGREEMENT 
  
 In consideration of my employment or continued employment by PETCO Animal Supplies, Inc. (the “COMPANY”), and the compensation now and hereafter
paid to me, I, David Bolen, (“Executive”), hereby agree as follows: 
  

	1.	NONDISCLOSURE 

  
 1.1 RECOGNITION OF COMPANY’S RIGHTS; NONDISCLOSURE. 
  
 At all times during my employment and thereafter, I will hold in strictest confidence and will not disclose, use, lecture upon or publish any of the
Company’s Proprietary Information (defined below), except as such disclosure, use or publication may be required in connection with my work for the Company, or unless the CEO of the Company expressly authorizes such in writing. I will obtain
Company’s written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that relates to my work at Company and/or incorporates any Proprietary Information. I hereby assign to the Company any
rights I may have or acquire in such Proprietary information and recognize that all Proprietary Information shall be the sole property of the Company and its assigns. 
  
 1.2 PROPRIETARY INFORMATION. The term “PROPRIETARY INFORMATION” shall mean any and all confidential and/or
proprietary knowledge, data or information of the Company. By way of illustration but not limitation, “PROPRIETARY INFORMATION” includes (a) trade secrets, inventions, mask works, ideas, processes, formulas, source and object codes,
data, programs, other works of authorship, know-how, improvements, discoveries developments, designs and techniques (hereinafter collectively referred to as “INVENTIONS”); and (b) information regarding plans for research, development,
new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; and (c) information regarding the skills and compensation of other employees of the Company.
Notwithstanding the foregoing, it is understood that, at all such times, I am free to use information which is generally known in the trade or industry, which is not gained as result of a breach of this Agreement, and my own, skill, knowledge,
know-how and experience to whatever extent and in whichever way I wish. 
  
 1.3 THIRD PARTY INFORMATION. I understand, in addition, that the Company has received and in the future will receive from third parties confidential or proprietary information (“THIRD PARTY INFORMATION”) subject to a duty on the
Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the term of my employment and thereafter, I will hold Third Party Information in the strictest 

  

 15 

 
confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for the Company) or
use, except in connection with my work for the Company, Third Party Information unless expressly authorized by an officer of the Company in writing. 
  
 1.4 NO IMPROPER USE OF INFORMATION OF PRIOR EMPLOYERS AND OTHERS. During my employment by the Company I will not improperly use or disclose any
confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto the premises of the Company any unpublished documents or any property belonging
to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in writing by that former employer or person. I will use in the performance of my duties only information which is generally known and
used by persons with training and experience comparable to my own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. 
  

	2.	ASSIGNMENT OF INVENTIONS. 

  
 2.1 PROPRIETARY RIGHTS. The term “PROPRIETARY RIGHTS” shall mean all trade secret, patent, copyright, mask work and other intellectual property
rights throughout the world. 
  
 2.2 PRIOR INVENTIONS. Inventions,
if any, patented or unpatented, which I made prior to the commencement of my employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, I have set forth on Exhibit B (Previous Inventions)
attached hereto a complete list of all Inventions that I have, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with the
Company, that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement (collectively referred to as “PRIOR INVENTIONS”). If disclosure of any such Prior Invention would
cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in Exhibit B but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the
fact that full disclosure as to such inventions has not been made for that reason. A space is provided on Exhibit B for such purpose. If no such disclosure is attached, I represent that there are no Prior Inventions. If, in the course of my
employment with the Company, I incorporate a Prior Invention into a Company product, process or machine, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense
through multiple tiers of sublicensees) to make, have made, modify, use and sell such Prior Invention. Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions
without the Company’s prior written consent. 
  

 16 

 2.3 ASSIGNMENT OF INVENTIONS. Subject to Sections 2.4, and 2.6, I hereby assign and agree to assign in
the future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any and all Inventions (and all Proprietary Rights
with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my employment with the Company.
Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this Section 2, are hereinafter referred to as “COMPANY INVENTIONS.” 
  
 2.4 NONASSIGNABLE INVENTIONS. This Agreement does not apply to an Invention which qualifies fully as a nonassignable
Invention under Section 2870 of the California Labor Code (hereinafter “SECTION 2870”). I have reviewed the Notification on Exhibit A (Limited Exclusion Notification) and agree that my signature acknowledges receipt of the
notification. 
  
 2.5 OBLIGATION TO KEEP COMPANY INFORMED. During
the period of my employment I will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly with others. In addition, I will promptly disclose to the Company all
patent applications filed by me or on my behalf within six (6) months after termination of employment. At the time of each such disclosure, I will advise the Company in writing of any Inventions that I believe fully qualify for protection under
Section 2870; and I will at that time provide to the Company in writing all evidence necessary to substantiate that belief. The Company will keep in confidence and will not use for any purpose or disclose to third parties without my consent any
confidential information disclosed in writing to the Company pursuant to this Agreement relating to Inventions that qualify fully for protection under the provisions of Section 2870. I will preserve the confidentiality of any Invention that
does not fully qualify for protection under Section 2870. 
  
 2.6 GOVERNMENT OR THIRD PARTY. I also agree to assign all my right, title and interest in and to any particular Company Invention to a third party, including without limitation the United States, as directed by the Company. 
  
 2.7 WORKS FOR HIRE. I acknowledge that all original works of authorship which
are made by me (solely or jointly with others) within the scope of my employment and which are protectable by copyright are “works made for hire,” pursuant to United States Copyright Act (17 U.S.C., Section 101). 
  
 2.8 ENFORCEMENT OF PROPRIETARY RIGHTS. I will assist the Company in every
proper way to obtain, and from time to time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries. To that end I will execute, verify and deliver such documents and perform such other acts
(including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof. In 

  

 17 

 
addition, I will execute, verify and deliver assignments of such Proprietary Rights to the Company or its designee. My obligation to assist the Company with
respect to Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my employment, but the Company shall compensate me at a reasonable rate after my termination for the time actually
spent by me at the Company’s request on such assistance. In the event the Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with the actions specified in this
Section 2.8, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act for and in my behalf to execute, verify and
file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by me. I hereby waive and quitclaim to the Company any and all claims, of any
nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company. 
  

	3.	RECORDS. 

  
 I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that may be required by the Company) of all Proprietary information developed by me and all
Inventions made by me during the period of my employment at the Company, which records shall be available to and remain the sole property of the Company at all times. 
  

	4.	ADDITIONAL ACTIVITIES. 

  
 I agree that during the period of my employment by the Company I will not without the Company’s express written consent, engage in any employment or
business activity which is competitive with, or would otherwise conflict with, my employment by the Company. I agree further that for the period of my employment by the Company and for one (1) year after the date of termination of my employment
by the Company I will not induce any employee of the Company to leave the employ of the Company. 
  

	5.	NO CONFLICTING OBLIGATION. 

  
 I represent that my performance of all the terms of this Agreement and as an employee of the Company does not and will not breech any agreement to keep in
confidence information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will not enter into, any agreement either written or oral in conflict herewith. 
  

	6.	RETURN OF COMPANY DOCUMENTS. 

  
 When I leave the employ of the Company, I will deliver to the Company any and all drawings, notes, memoranda, specifications, devices, formulas, and
documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Proprietary 

  

 18 

 
Information of the Company. I further agree that any property situated on the Company’s premises and owned by the Company, including disks and other
storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at any time with or without notice. 
  

	7.	LEGAL AND EQUITABLE REMEDIES. 

  
 Because my services are personal and unique and because I may have access to and become acquainted with the Proprietary Information of the Company, the
Company shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief, without bond and without prejudice to any other rights and remedies that the Company may have for a
breach of this Agreement, including paragraph 16 of my Employment Agreement which requests Arbitration. 
  

	8.	NOTICES. 

  
 Any notices required or permitted hereunder shall be given to the appropriate party at the address listed in Employment Agreement. Such notice shall be deemed given upon personal delivery to the appropriate address or
if sent by certified or registered mail, three (3) days after the date of mailing. 
  

	9.	NOTIFICATION OF NEW EMPLOYER. 

  
 In the event that I leave the employ of the Company, I hereby consent to the notification of my new employer of my rights and obligations under this
Agreement. 
  

	10.	GENERAL PROVISIONS. 

  
 10.1 GOVERNING LAW; CONSENT TO PERSONAL JURISDICTION. This Agreement will be governed by and construed according to the laws of the State of California,
as such laws are applied to agreements entered into and to be performed entirely within California between California residents. I hereby expressly consent to the personal jurisdiction of the state and federal courts located in San Diego County,
California for any lawsuit filed there against me by Company arising from or related to this Agreement. 
  
 10.2 SEVERABILITY. In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or
unenforceable in any respect such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been
contained herein. 
  
 10.3 SUCCESSORS AND ASSIGNS. This Agreement
will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 
  

 19 

 10.4 SURVIVAL. The provisions of this Agreement shall survive the termination of my employment and the
assignment of this Agreement by the Company to any successor in interest or other assignee. 
  
 10.5 EMPLOYMENT. I agree and understand that nothing in this Agreement shall confer any right with respect to continuation of employment by the Company, which is governed by my Employment Agreement. 
  
 10.6 WAIVER. No waiver by the Company of any breach of this Agreement shall
be a waiver of any preceding or succeeding breach. No waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right. The Company shall not be required to give notice to enforce strict adherence to all
terms of this Agreement. 
  
 10.7 ENTIRE AGREEMENT. The
obligations pursuant to Sections 1 and 2 of this Agreement shall apply to any time during which I was previously employed, or am in the future employed, by the Company as a consultant if no other agreement governs nondisclosure and assignment of
inventions during such period. Except for my Employment Agreement, this Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof. In the event of any conflict between the terms of this
Agreement and my Employment Agreement, my Employment Agreement shall prevail. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be
charged. 
  
 I HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS. I HAVE
COMPLETELY FILLED OUT EXHIBIT B TO THIS AGREEMENT. 
  

							
				
	 Dated:
	 	  	 	 	 	  
	 	 	 	 	 	 	 David Bolen

			
	ACCEPTED AND AGREED TO:	 	 	 	 
			
	 PETCO Animal Supplies, Inc.
	 	 	 	 
				
	 Dated:
	 	  	 	 	 	  
	 	 	 	 	 	 	 James Myers, CEO

  

 20 

 EXHIBIT A 
  

LIMITED EXCLUSION NOTIFICATION 
  
 THIS IS TO NOTIFY you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you and the Company does not require you to
assign or offer to assign to the Company any invention that you developed entirely on your own time without using the Company’s equipment, supplies, facilities or trade secret information except for those inventions that either: 
  

	 	1.	Relate at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or development of the
Company; 

  

	 	2.	Result from any work performed by you for the Company. To the extent a provision in the foregoing Agreement purports to require you to assign an invention otherwise excluded from
the preceding paragraph, the provision is against the public policy of this state and is unenforceable. This limited exclusion does not apply to any patent or invention covered by a contract between the Company and the United States or any of its
agencies requiring full title to such patent or invention to be in the United States. 

  
 I ACKNOWLEDGE RECEIPT of a copy of this notification. 
  

							
				
	 Dated:
	 	  	 	 	 	  
	 	 	 	 	 	 	 David Bolen

			
	ACCEPTED AND AGREED TO:	 	 	 	 
			
	 PETCO Animal Supplies, Inc.
	 	 	 	 
				
	 Dated:
	 	  	 	 	 	  
	 	 	 	 	 	 	 James Myers, CEO

  

 21 

 EXHIBIT B 
  

	TO:	PETCO Animal Supplies, Inc. 

  

	FROM:	David Bolen 

  

	DATE:	                                      
               

  

	SUBJECT:	PREVIOUS INVENTIONS 

  
 1. Except as listed in Section 2 below, the following is a complete list of all inventions or improvements relevant to the subject matter of my employment by PETCO Animal Supplies, Inc. (the “COMPANY”)
that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company: x No inventions or improvements.  ̈ See below:
                                        
        
                                        
        
                                        
          ̈ Additional sheets attached. 
  
 2. Due to a prior confidentiality agreement, I cannot complete the disclosure under Section 1 above with respect to inventions or
improvements generally listed below, the proprietary rights and duty of confidentiality with respect to which I owe to the following party(ies): INVENTION OR IMPROVEMENT PARTY(IES) RELATIONSHIP
                                        
                    
                     1.
                            
                    
                     2.
                            
                    
                     3.
                            
                    
                     
  

 22 

 EXHIBIT C 
  

PETCO RELOCATION REPAYMENT AGREEMENT 
  
 This Relocation Repayment Agreement is made between PETCO Animal Supplies, Inc. (“PETCO”) and the undersigned associate (“Associate”).

  
 Associate has accepted employment with PETCO and will receive
certain relocation advances from PETCO as described on the attached letter. Associate has agreed to repay a portion of the advances if employment is terminated voluntarily by associate or for cause by PETCO prior to a specified date,
all as more clearly set forth in this Agreement. 
  
 In consideration of the
mutual covenants of the Agreement, both parties agree to the following: 
  

	 	1.	REIMBURSEMENT OF EXPENSES: Associate agrees to reimburse PETCO for a portion of the relocation expenses received if his/her employment is terminated either
voluntarily by the associate or for cause by PETCO within two years of the Associate’s employment date; all as set forth in the letter. The amount of repayment to PETCO by the Associate shall be determined by dividing the
advance by 730 and multiplying the result by the number of days from the termination date to the second anniversary date of the Associate. The Associate agrees that this obligation to reimburse PETCO shall arise in the event of
termination or employment within two years from the employment date unless the termination is the result of layoff or reduction in force. 

  

	 	2.	AUTHORIZATION TO WITHOLD: The Associate hereby authorizes PETCO to withhold any sums due to PETCO pursuant to this Agreement from his/her final paycheck.
This authorization will not preclude PETCO from pursuing legal action to collect any amounts due. 

  

	 	1.	Governing Law and Venue: This Agreement shall be construed and enforced according to the laws of the State of California. 

  
 I have read, understood and agree to the above terms. 
  

									
					
	Associate:	 	 	 	 	 	 Date:
	 	 
					
	PETCO:	 	 	 	 	 	 Date:
	 	 

  

 23Securities Purchase Agreement

 Exhibit 10.1 
  
 SECURITIES PURCHASE AGREEMENT 
  

This Securities Purchase Agreement (this “Agreement”) is dated as of January 19, 2006, by and between eMerge Interactive Inc., a
Delaware corporation (the “Company”), and The Biegert Family Irrevocable Trust, dated June 11, 1998 (the “Purchaser”). 
  
 WHEREAS, subject to available exemptions from registration contained in the Securities Act of 1933, as amended (the “Securities Act”),
the Company desires to issue and sell to the Purchaser, and the Purchaser, desires to purchase from the Company, securities of the Company as more fully described in this Agreement; and 
  
 WHEREAS, the Purchaser desires to exercise a warrant to purchase securities of the Company as more fully described in this
Agreement. 
  
 NOW, THEREFORE, IN CONSIDERATION of the mutual
covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agrees as follows: 
  
 ARTICLE I 
 DEFINITIONS 
  
 1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings indicated in this Section 1.1: 
  
 “Action” shall have the meaning ascribed to
such term in Section 3.1(j). 
  
 “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 144.

  
 “Business Day” means any day
except Saturday, Sunday and any day which shall be a federal legal holiday or a day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. 
  
 “Closing” means the closing of the purchase
and sale of the Common Stock and the Warrants pursuant to Section 2.1. 
  
 “Closing Date” means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to the Closing set forth in
Section 2.2 have been satisfied or waived. 
  
 “Commission” means the Securities and Exchange Commission. 
  
 “Common Stock” means the common stock of the Company, $0.008 par value per share, and any securities into which such
common stock may hereafter be reclassified. 

 “Common Stock Equivalents” means any securities of the Company which
would entitle the holder thereof to acquire at any time Common Stock, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise
entitles the holder thereof to receive, Common Stock. 
  
 “Disclosure Schedules” means the Disclosure Schedules delivered concurrently herewith. 
  
 “Effective Date” means the date that the Registration Statement is first declared effective by the Commission.

  
 “Exchange Act” means the
Securities Exchange Act of 1934, as amended. 
  
 “Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(o). 
  
 “Liens” means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other
restriction. 
  
 “Material Adverse
Effect” shall have the meaning assigned to such term in Section 3.1(b). 
  
 “Material Permits” shall have the meaning ascribed to such term in Section 3.1(m). 
  
 “Per Share Purchase Price” equals $0.36.

  
 “Person” means an individual
or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 
  
 “Registration Statement” means the
registration statement to be filed by the Company pursuant to the Registration Rights Agreement. 
  
 “Registration Rights Agreement” means the Registration Rights Agreement, dated as of the date of this Agreement, among
the Company and the Purchaser, in the form of Exhibit A hereto. 
  
 “Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e). 
  
 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
  
 “SEC Reports” shall have the meaning ascribed to such term in Section 3.1(h). 

 “Securities” means the Shares, the Warrant and the Warrant Shares.

  
 “Securities Act” shall have
the meaning ascribed to such term in the Preamble. 
  
 “Shares” means the shares of Common Stock issued or issuable to the Purchaser pursuant to this Agreement. 
  
 “Subscription Amount” means the amount set forth below the Purchaser’s signature block on the signature page hereto,
in United States dollars and in immediately available funds. 
  
 “Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market, or (ii) if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is
traded on the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on the OTC Bulletin Board, a day on which the Common Stock is quoted in the over-the-counter market as reported by the Pink
Sheets LLC (or any similar organization or agency succeeding its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall
mean a Business Day. 
  
 “Trading
Market” means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the American Stock Exchange, the New York Stock Exchange, the Nasdaq National Market or the Nasdaq SmallCap
Market. 
  
 “Transaction
Documents” means this Agreement, the Warrant and the Registration Rights Agreement and any other documents or agreements executed in connection with the transactions contemplated hereunder. 
  
 “Warrant” means the Common Stock purchase
warrant, in the form of Exhibit B, issuable to the Purchaser at the Closing, which shall be exercisable no earlier than six months after the Closing Date and have an exercise price equal to 110% of the last reported closing price per share of
Common Stock on the Trading Day immediately preceding the Closing Date (as reported by Bloomberg L.P.) and be exercisable for five years. 
  
 “Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrant. 
  
 ARTICLE II 
 PURCHASE AND SALE 
  
 2.1 Closing. At the Closing, the Purchaser shall purchase from the Company and the Company shall issue and sell to the Purchaser, (a) a number of Shares equal to the Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrant. Upon satisfaction of the conditions set forth in Section 2.2, the Closing shall occur at such location as the parties agree. 

 2.2 Closing Conditions 
  
 (a) At the Closing the Company shall deliver or cause to be delivered to the Purchaser the following: 
  
 (i) this Agreement duly executed by the Company; 
  
 (ii) promptly following the Closing Date, a certificate evidencing 8,000,000
shares of Common Stock (representing the number of Shares equal to the Purchaser’s Subscription Amount divided by the Per Share Purchase Price) registered in the name of the Purchaser; 
  
 (iii) the Warrant, registered in the name of the Purchaser, pursuant to
which the Purchaser shall have the right to purchase up to 5,000,000 shares of Common Stock (representing the number of shares of Common Stock equal to 62.5% of the Shares to be issued to the Purchaser at the Closing); and 
  
 (iv) the Registration Rights Agreement duly executed by the Company.

  
 (b) At the Closing the Purchaser shall deliver or cause to be
delivered to the Company the following: 
  
 (i) this Agreement
duly executed by the Purchaser; 
  
 (ii) the Purchaser’s
Subscription Amount by wire transfer to an account as specified in writing by the Company; 
  
 (iii) the Registration Rights Agreement duly executed by the Purchaser; 
  
 (iv) the Warrant, dated as of November 20, 2003 (the “2003 Warrant”), including a Notice of Exercise executed by the Purchaser for
a total of 802,568 Shares; and 
  
 (v) a wire transfer by the
Purchaser to an account as specified in writing by the Company for an amount of $288,924.48 as consideration for the Shares purchased pursuant to the Purchaser’s exercise of the 2003 Warrant. 
  
 (c) All representations and warranties of the other party contained herein
shall remain true and correct as of the Closing Date and all covenants of the other party shall have been performed if due prior to such date. 
  
 (d) The Nasdaq Stock Market shall have waived application of the 15 day prior notice contained in NASD Marketplace Rule 4310(c)(17)(D) or such timeframe
shall have expired without objection. 
  
 2.3 Notwithstanding any
provision of this Agreement or any of the other Transaction Documents, under no circumstances shall the terms of this Agreement or any of the other Transaction Documents require the Company to issue shares of Common Stock or Common Stock Equivalents
to the Purchaser to the extent that either (i) such issuance would equal 20% or 

 more of the Common Stock or 20% or more of the voting power outstanding before such issuance or (ii) following such
issuance, the Purchaser would, individually or as part of a group (as defined in Section 13(d)(3) of the Securities Act), directly or indirectly own 20% or more of the Common Stock or 20% or more of the voting power outstanding, in either case
without prior stockholder approval. Upon the written request of the Purchaser, the Company agrees to seek stockholder approval of any such issuance at the Company’s next regularly scheduled annual meeting of stockholders. 
  
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES 
  
 3.1 Representations and Warranties of the Company. Except as set forth under the corresponding section of the disclosure schedules delivered to the Purchaser concurrently herewith (the “Disclosure
Schedules”), which Disclosure Schedules shall be deemed a part hereof, the Company hereby makes the representations and warranties set forth below to the Purchaser: 
  
 (a) Subsidiaries. The Company has no direct or indirect subsidiaries. 
  
 (b) Organization and Qualification. The Company is an entity duly
incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, with the requisite power and authority to own and use its properties and assets and to carry on its business as
currently conducted. The Company is not in violation of any of the provisions of its certificate of incorporation or bylaws. The Company is duly qualified to do business and is in good standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not, individually or in the aggregate:
(i) materially adversely affect the legality, validity or enforceability of any Transaction Document, (ii) have or result in or be reasonably likely to have or result in a material adverse effect on the results of operations, assets,
business or condition (financial or otherwise) of the Company, or (iii) materially adversely impair the Company’s ability to perform fully on a timely basis its obligations under any of the Transaction Documents (any of (i), (ii) or
(iii), a “Material Adverse Effect”). 
  
 (c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder or
thereunder. The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby or thereby have been duly authorized by all necessary action on the part of the Company and
no further consent or action is required by the Company other than Required Approvals. Each of the Transaction Documents has been (or upon delivery will be) duly executed by the Company and, when delivered in accordance with the terms hereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws affecting
creditors’ rights and remedies generally and general principles of equity. 

 (d) No Conflicts. The execution, delivery and performance of the Transaction Documents by the
Company and the consummation by the Company of the transactions contemplated thereby do not and will not: (i) conflict with or violate any provision of the Company’s certificate of incorporation or bylaws, or (ii) subject to obtaining
the Required Approvals, conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any material agreement, credit facility, debt or other instrument to which the Company is a party or by which any property or asset of the Company is bound or affected, or (iii) result, in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject, or by which any property or asset of the Company is bound or affected; except in the case
of each of clauses (ii) and (iii), such as does not, individually or in the aggregate, have or result in a Material Adverse Effect. 
  
 (e) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than
(i) the filing with the Commission of the Registration Statement, (ii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, including
the notice described in Section 2.2(d), and (iii) the filing of Form D with the Commission and such filings as are required to be made under applicable securities laws (where (i)-(iii) are collectively the “Required
Approvals”). 
  
 (f) Issuance of the Securities.
The Shares and Warrant are duly authorized and, when issued and paid for in accordance with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. 
  
 (g) Capitalization. The capitalization of the Company is as described in the Company’s most recent periodic
report filed with the Commission. The Company has not issued any capital stock since such filing other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to
employees pursuant to the Company’s employee stock purchase plan and pursuant to the conversion or exercise of outstanding Common Stock Equivalents. No Person has any right of first refusal, preemptive right, right of participation, or any
similar right to participate in the transactions contemplated by the Transaction Documents. 
  
 (h) SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for
the two years preceding the date hereof (or such shorter period as the Company was required by law to file such material) (the foregoing materials being 

 collectively referred to herein as the “SEC Reports”). The Company has identified and made available to
the Purchaser a copy of all SEC Reports filed within the 10 days preceding the date hereof. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the
rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and
the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the
periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments and the absence of footnotes. 
  
 (i) Material Changes. Since the date of the latest audited financial
statements included within the SEC Reports, except as specifically disclosed in the SEC Reports: (i) there has been no event, occurrence or development that has had or that could result in a Material Adverse Effect, (ii) the Company has
not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the
Company’s financial statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting or the identity of its auditors, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v) the Company has not issued any equity
securities to any officer, director or Affiliate, except pursuant to existing Company stock option or similar plans. 
  
 (j) Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company,
threatened against or affecting the Company or any of its respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an
“Action”) which: (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, individually or in
the aggregate, have or reasonably be expected to result in a Material Adverse Effect. 
  
 (k) Labor Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company which could reasonably be expected to result in a
Material Adverse Effect. 
  
 (l) Compliance. The Company:
(i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, 

 would result in a default by the Company under), nor has the Company received notice of a claim that it is in default
under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived),
(ii) is in violation of any order of any court, arbitrator or governmental body, or (iii) is or has been in violation of any statute, rule or regulation of any governmental authority, except in each case as could not, individually or in
the aggregate, have or result in a Material Adverse Effect. 
  
 (m) Regulatory Permits. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as
described in the SEC Reports, except where the failure to possess such permits could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and the Company
has not received any notice of proceedings relating to the revocation or modification of any Material Permit. 
  
 (n) Title to Assets. The Company has no real property. Any real property and facilities held under lease by the Company are held under valid,
subsisting and enforceable leases of which the Company is in compliance, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. 
  
 (o) Patents and Trademarks. The Company has rights to use, all
patents, patent applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses and other similar rights necessary or material for use in connection with their respective businesses as described in the SEC Reports
and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). The Company has not received a written notice that the Intellectual Property Rights used by the Company
violates or infringes upon the rights of any Person. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.

  
 (p) Insurance. The Company is insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company is engaged. To the Company’s knowledge, such insurance contracts and policies are accurate
and complete. The Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business.

  
 (q) Transactions With Affiliates and Employees. Except
as required to be set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other than for
services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, 

 director, trustee or partner, in each case in excess of $60,000 other than (i) for payment of salary or consulting
fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) for other employee benefits, including stock option agreements under any stock option plan of the Company. 
  
 (r) Certain Fees. Except as set forth in this Agreement, no brokerage
or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this
Agreement, and the Company has not taken any action that would cause the Purchaser to be liable for any such fees or commissions. The Company agrees that the Purchaser shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of any Person for fees of the type contemplated by this Section with the transactions contemplated by this Agreement. 
  
 (s) Private Placement. Assuming the accuracy of the Purchaser representations and warranties set forth in Section 3.2, no registration under
the Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser as contemplated hereby in accordance with the terms of the Transaction Documents. The issuance and sale of the Securities hereunder does not
contravene the rules and regulations of the Trading Market. 
  
 (t) Investment Company. The Company is not, and is not an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 
  
 (u) Registration Rights. Except as set forth on the disclosure
schedule to the Registration Rights Agreement, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company that have not been satisfied. 
  
 (v) Tax Status. The Company has made or filed all federal, state and
foreign income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company has set aside on its books provisions reasonably adequate for the payment of all
unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and
has set aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by
the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating to the assessment or collection of any foreign,
federal, statue or local tax. None of the Company’s tax returns is presently being audited by any taxing authority. 
  
 (w) Disclosure. All disclosure provided to the Purchaser regarding the Company, its business and the transactions contemplated hereby, including
the Schedules to this Agreement, furnished by or on behalf of the Company with respect to the representations and warranties made herein are true and correct with respect to such representations and warranties 

 and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make
the statements made therein, in light of the circumstances under which they were made, not misleading. 
  
 (x) No Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2, neither the
Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of
the Securities to be integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder approval provisions, including, without limitation, under the rules and regulations of any exchange or automated
quotation system on which any of the securities of the Company are listed or designated. 
  
 (y) Solvency. Based on the financial condition of the Company as of the Closing Date after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the
Company’s fair saleable value of its assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known contingent liabilities) as they mature; (ii) the
Company’s assets do not constitute unreasonably small capital to carry on its business for the current fiscal year as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital
requirements of the business conducted by the Company, and projected capital requirements and capital availability thereof; and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its debt when such amounts are required to be paid. The Company does not intend to incur debts beyond
its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). 
  
 (z) Acknowledgment Regarding Purchaser’s Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely in
the capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. 
  
 (aa) Form S-3 Eligibility. The Company is eligible to register the resale of its Common Stock by the Purchaser under Form S-3 promulgated under the
Securities Act. 
  
 3.2 Representations and Warranties of the
Purchaser. The Purchaser hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows: 
  
 (a) Organization; Authority. The Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of
its organization with full right, corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations thereunder. The execution, delivery
and performance by the Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate action on the part of the Purchaser. Each Transaction Document to which it is party has been duly executed by
the Purchaser, and when delivered by the Purchaser in accordance 

 with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it
in accordance with its terms except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

  
 (b) Investment Intent. The Purchaser understands that
the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account for investment purposes only and not
with a view to or for distributing or reselling such Securities or any part thereof, has no present intention of distributing any of such Securities and has no arrangement or understanding with any other Persons regarding the distribution of such
Securities (this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). The Purchaser does not
have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Securities. 
  
 (c) Purchaser Status. At the time the Purchaser was offered the Securities, it was, and at the date hereof it is, and on each date on which it
exercises any Warrants, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in
Rule 144A(a) under the Securities Act. The Purchaser is not required to be registered as a broker-dealer under Section 15 of the Exchange Act. 
  
 (d) Experience of such Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the
economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. 
  
 (e) General Solicitation. The Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement. 
  
 (f) Residence. The office or offices of the Purchaser in which its
investment decision was made is located at the address or addresses of the Purchaser set forth on the signature page hereto. 
  
 (g) Access to Information. The purchaser has had access to and has received all of the information it has deemed necessary to make an informed
investment decision with respect to an acquisition of the Securities. 

 ARTICLE IV 
 OTHER AGREEMENTS OF THE PARTIES 
  
 4.1 Transfer Restrictions. The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule
144, to the Company or to an Affiliate of the Purchaser, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement
and shall have the rights of the Purchaser under this Agreement and the Registration Rights Agreement. 
  
 (b) The Purchaser agrees to the imprinting, so long as is required by this Section 4.1(b), of the following legend on any certificate evidencing
Securities: 
  
 THESE SECURITIES HAVE NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR
SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE
501(a) UNDER THE SECURITIES ACT. 
  
 (c) The Purchaser agrees that
the removal of the restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company’s reliance that the Purchaser will sell any Securities pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom. 
  
 4.2 Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Purchaser or that would be
integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is
obtained before the closing of such subsequent transaction. 
  
 4.3 Use of Proceeds. Except as set forth on Schedule 4.3 attached hereto, the Company shall use the net proceeds from the sale of the Securities hereunder for working capital 

 purposes and not for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in
the ordinary course of the Company’s business and prior practices), to redeem any Company equity or equity-equivalent securities or to settle any outstanding litigation. 
  
 4.4 Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to
reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the
Warrants. 
  
 4.5 Listing of Common Stock. The Company
hereby agrees to use commercially reasonably efforts to maintain the listing of the Common Stock on the Trading Market, and as soon as reasonably practicable following the Closing (but not later than the earlier of the Effective Date and the first
anniversary of the Closing Date) to list all of the Shares and Warrant Shares on the Trading Market. 
  
 4.6 Market Standoff. Purchaser agrees that, without the prior written consent of the Board of Directors of the Company, Purchaser shall not
acquire, whether directly or indirectly or whether individually or as part of a group (as defined in Section 13(d)(3) of the Securities Act), a number of shares of Common Stock exceeding 1% of the Company’s shares of Common Stock
outstanding during any 12-month period, except for the Warrant Shares. 
  
 ARTICLE V 
 MISCELLANEOUS 
  
 5.1 Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other
expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. 
  
 5.2 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. 

 
 5.3 Notices. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile
number set forth on the signature pages attached hereto prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the
facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 5.4 Amendments; Waivers. No provision of this Agreement may be waived or amended except in a
written instrument signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of any such right. 
  
 5.5 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or
obligations hereunder without the prior written consent of the Purchaser. The Purchaser may assign its rights under this Agreement and the Registration Rights Agreement to any Person to whom the Purchaser assigns or transfers any Securities.

  
 5.6 No Third-Party Beneficiaries. This Agreement is
intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 
  
 5.7 Governing Law. All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof. 
  
 5.8 Execution. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile signature page were an original thereof. 
  
 5.9 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in
any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision into this Agreement.

  
 5.10 Remedies. In addition to being entitled to
exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

  
 (Signature Page Follows) 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated above. 
  

			
	eMERGE INTERACTIVE INC.
		
	 By:
	 	 /s/ DAVID C. WARREN

	 Name:
	 	 David C. Warren

	 Title:
	 	 President and Chief Executive Officer

	
	 Address for Notice:

	
	 eMerge Interactive, Inc.

	 10305 102nd Terrace

	 Sebastian, Florida 32958

	 Attention: David C. Warren

	 Telephone: (772) 581-9741

	 Telecopy:   (772) 581-0204

	
	 With a copy to:

	
	 Hunton & Williams LLP

	 Riverfront Plaza, East Tower

	 951 East Byrd Street

	 Richmond, VA 23219

	 Attention: Gary Thompson

	 Telephone: (804) 788-8200

	 Facsimile:  (804) 788-8218

  
 [REMAINDER OF
PAGE INTENTIONALLY LEFT BLANK 
 SIGNATURE PAGE FOR PURCHASER FOLLOWS] 

 [PURCHASER’S SIGNATURE PAGE] 
  
 IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective
authorized signatories as of the date first indicated above. 
  

			
	Judith Ackland and Larry Cox, Co-Trustees of	  	Address for Notice:
	The Biegert Family Irrevocable Trust,	  	Biegert Feeds
	dated June 11, 1998	  	115 S. 14th Street
	 	  	Geneva, NE 68361
	 	  	Tel. (402) 759-4994
	 	  	Fax (402) 759-4995

  

			
	By:	 	 /s/ JUDITH ACKLAND

	Name:	 	Judith Ackland
	Title:	 	Trustee

  
 Subscription Amount: $2,880,000

 Shares: 8,000,000 
 Warrant Shares: 5,000,000 

 Exhibit A 
  
 REGISTRATION RIGHTS AGREEMENT 
  

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of January     , 2006, by and between
eMerge Interactive, Inc., a Delaware corporation (the “Company”), and The Biegert Family Irrevocable Trust, dated June 11, 1998 (the “Investor”). 
  
 RECITALS 
  
 1. The Company and the Investor are parties to that certain Securities Purchase Agreement, dated effective as of the date hereof (the “Purchase
Agreement”), relating to the terms of closing an investment in the Company’s Class A common stock, par value $0.008 per share (the “Common Stock”). 
  
 2. The obligations of the parties under the Purchase Agreement are conditioned, among other things, upon the execution and
delivery by the parties of this Agreement. 
  
 3. The Company and
the Investor desire to grant and to be granted the rights created in this Agreement. 
  
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows: 
  
 AGREEMENT 
  
 1. Definitions. In addition to the other terms defined in this
Agreement, the following terms shall have the following meanings: 
  
 (a) “Commission” means the United States Securities and Exchange Commission, or any other federal agency at the time administering the Securities Act. 
  
 (b) “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any similar federal statute,
and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
  
 (c) “Person” means an individual, a corporation, a partnership, a limited liability company, a joint venture, a trust, an estate, an
unincorporated organization, a government and any agency or political subdivision thereof. 
  
 (d) “Registrable Securities” means (i) the Shares issued pursuant to the Purchase Agreement, (ii) the Shares issuable upon exercise of the Warrant issued pursuant to the Purchase Agreement;
and (iii) any other securities of the Company distributable on, with respect to, or in substitution of, such Shares, except in either case for those that have been registered, sold or transferred pursuant to an effective Registration Statement,
or are available for sale or transfer pursuant to Rule 144 under the Securities Act. 

 (e) “Registration Expenses” means all expenses incurred in effecting the registration
provided for in Section 2, including without limitation all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, underwriting expenses (other than fees, commissions or discounts) and Company
expenses of complying with the securities or blue sky laws of any jurisdictions (but excluding fees and disbursements of counsel and other agents for the selling holders of Registrable Securities). 
  
 (f) “Securities Act” means the Securities Act of 1933, as
amended, or any similar federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
  
 (g) All other terms used herein but not otherwise defined shall have the meanings ascribed to them in the Purchase Agreement. 
  
 2. Demand Registration. 
  
 (a) On or prior to [October     , 2006] [nine
(9) months following the date hereof] (the “Filing Date”), the Company shall prepare and file with the Commission the Registration Statement covering the resale of all of the Registrable Securities (and including, for purposes
of this number, any securities which may be issuable upon any stock split, dividend or other distribution or recapitalization provision in the Warrants or in connection with any anti-dilution provisions in the Warrants) for an offering to be made on
a continuous basis pursuant to Rule 415. Subject to the terms of this Agreement, the Company shall use its reasonable best efforts to cause the Registration Statement to be declared effective under the Securities Act as promptly as possible after
the filing thereof, but in any event prior to [January     , 2007] [twelve (12) months following the date hereof] (the “Effectiveness Date”), and shall use its reasonable best efforts to keep the
Registration Statement continuously effective under the Securities Act until the date which is two years after the date that the Registration Statement is declared effective by the Commission or such earlier date when all Registrable Securities
covered by the Registration Statement have been sold or may be sold without limitation due to volume restrictions (the “Effectiveness Period”). The Investor may sell such Registrable Securities in an offering pursuant to this
Section 2 that is underwritten (“Underwritten Offering”). In an Underwritten Offering, the investment banker or investment bankers and manager or managers that will administer the offering will be selected by the holders
of a majority of the Registrable Securities included in the offering, subject to approval of the Company (which will not be unreasonably withheld). 
  
 (b) A Registration Statement filed pursuant to the request of the Investor may include other securities of the Company with respect to which
“piggy-back” registration rights have been granted, and may include securities of the Company being sold for the account of the Company; provided, however, that if the Company shall request inclusion in any registration
pursuant to this Section 2 of the securities being sold for its own account, or if other persons shall request inclusion in any registration undertaken pursuant to this Section 2, the Investor shall, on behalf of all entities
requesting inclusion in such registration, offer to include such securities in the offering; provided, however, that the Investor may condition any such offer on its acceptance of reasonable conditions (including, without limitation,
if such offering is an Underwritten Offering, that the Company or any other such requesting holders agree in writing 
  

 2 

 to enter into an underwriting agreement with usual and customary terms). Notwithstanding any other provisions of this
Section 2, if the representative of the underwriters advises the Investor in writing that marketing factors require a limitation on the number of shares to be underwritten, the number of shares to be underwritten and included in the
registration shall be allocated: (i) first, to the Investor requiring registration, (ii) second, to the Company and (iii) third, to the other holders requesting inclusion in the registration, pro rata among the respective
holders thereof on the basis of the number of shares for which each such requesting holder has requested registration. If a Person who has requested inclusion in such registration as provided above does not agree to the terms of any such
underwriting, such Person shall be excluded therefrom by written notice from the Company, the underwriter or the Investor. The securities so excluded shall also be withdrawn from registration. 
  
 (c) The Company shall immediately notify the Investor and such holders that
were included in the registration (collectively, the “Holders”) via facsimile of the effectiveness of the Registration Statement on the same day that the Company receives notification of the effectiveness from the Commission. 

 
 (d) If: (i) a Registration Statement is not filed on or prior to its
Filing Date (if the Company files a Registration Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) hereof, the Company shall not be deemed to have satisfied this clause (i)),
or (ii) a Registration Statement is not declared effective by the Commission on or prior to its required Effectiveness Date, or (iii) after its Effective Date, without regard for the reason thereunder or efforts therefore, such
Registration Statement ceases for any reason to be effective and available to the Holders as to all Registrable Securities which it is required to cover at any time prior to the expiration of its Effectiveness Period, for an aggregate of 20 Trading
Days for all such events (any such failure or breach being referred to as an “Event,” and for purposes of clauses (i), and (ii) or for purposes of clause (iii) the date on which such 20 Trading Day period is exceeded,
being referred to as and “Event Date”), then, in addition to any other rights available to the Holders under the Transaction Documents or under applicable law, (x) on each such Event Date the Company shall pay to each Holder an
amount in cash, as partial liquidated damages and not as a penalty, equal to 1.0% of the aggregate Subscription Amount of such Holder pursuant to the Purchase Agreement; and (y) on each monthly anniversary of each such Event Date thereof (if
the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 2.0% of the aggregate Subscription
Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of
12% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such liquidated damages are due until such amounts, plus all such interest thereon, are paid in full.
The parties agree that the Company will not be liable for liquidated damages under this Section in respect of the Warrant Shares. The liquidated damages pursuant to the terms hereof shall apply on a pro rata basis for any portion of a month
prior to the cure of an Event. 
  

 3 

 (e) Except as provided in Section 2(a) with respect to withdrawn Registration Statements, all
Registration Expenses of the Investor incurred in connection with the registration requested pursuant to this Section 2 will be borne by the Company. 
  
 3. “Piggy-Back” Registrations. 
  
 (a) If the Company decides to register any of its Common Stock or securities convertible into or exchangeable for Common
Stock under the Securities Act on a form which is suitable for an offering for cash of shares of the Company held by third parties and which is not a registration solely to implement an employee benefit plan, a Registration Statement on Form S-4 (or
successor form) or a transaction to which Rule 145 or any other similar rule of the Commission is applicable, the Company will promptly give written notice to the Investor of its intention to effect such a registration. Subject to
Section 3(b) below, the Company will use its reasonable efforts to effect the registration under the Securities Act of all Registrable Securities that the Investor requests be included in such registration by a written notice delivered
to the Company within 15 days after the notice given by the Company. The Investor agrees that any securities it requests to be included in a Company registration pursuant to this Section 3 will be included by the Company on the same form
of Registration Statement as has been selected by the Company for the securities the Company is registering for sale for its own account. 
  
 (b) If the registration involves an Underwritten Offering, the Company will not be required to register Registrable Securities in excess of the amount
that the principal underwriter reasonably and in good faith recommends may be included in such offering (a “Cutback”), which recommendation, and supporting reasoning, shall be delivered to the Investor. If such a Cutback occurs, the
number of shares that are entitled to be included in the registration and underwriting shall be allocated in the following manner: (i) first, to the Company for any securities it proposes to sell for its own account, (ii) second, to the
Investor, and (iii) third, to the other holders requesting inclusion in the registration, pro rata among the respective holders thereof on the basis of the number of shares for which each such requesting holder has requested
registration. 
  
 (c) If the Company elects to terminate any
registration filed under this Section 3, the Company will have no obligation to register the securities sought to be included by the Investor in such registration. If the Company includes in such registration any securities to be offered
by it, all Registration Expenses of the Investor will be borne by the Company. 
  
 4. Procedure for Registration. Whenever the Company is required under Section 2 to register Registrable Securities, it agrees to do the following: 
  
 (a) use its reasonable best efforts to keep such Registration Statement
continuously effective until the Investor may first sell any of the Registrable Securities under Rule 144 (i.e., one year from the Closing Date, as defined in the Purchase Agreement) in order to complete the proposed distribution; upon the
occurrence of any event that would cause the Registration Statement or the prospectus contained therein to contain a material misstatement or omission, file promptly an appropriate amendment to such Registration Statement correcting any such
misstatement or omission; 
  

 4 

 (b) prepare and file with the Commission a Registration Statement with respect to such Registrable
Securities and prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement as may be necessary to keep the Registration Statement effective for the period set forth in Section 4(a);
cause the prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities Act, and to comply fully with the applicable provisions of Rules 424 and 430A under the
Securities Act in a timely manner; and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement during the applicable period in accordance with the intended method or
methods of distribution by the sellers thereof set forth in such Registration Statement or supplement to the prospectus; 
  
 (c) advise the underwriter(s), if any, and selling Investor promptly and, if requested by such Persons, to confirm such advice in writing, (i) when
the prospectus or any prospectus supplement or post-effective amendment has been filed, and, with respect to the Registration Statement or any post-effective amendment thereto, when the same has become effective, (ii) of any request by the
Commission for amendments to the Registration Statement or amendments or supplements to the prospectus or for additional information relating thereto, (iii) of the issuance by the Commission of any stop order suspending the effectiveness of the
Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Registrable Securities for offering or sale in any jurisdiction, or the initiation of any proceeding for any of the
preceding purposes, and (iv) of the existence of any fact or the happening of any event that makes any statement of a material fact made in the Registration Statement, the prospectus, any amendment or supplement thereto, or any document
incorporated by reference therein untrue, or that requires the making of any additions to or changes in the Registration Statement or the prospectus in order to make the statements therein not misleading. If at any time the Commission shall issue
any stop order suspending the effectiveness of the Registration Statement or any state securities commission or other regulatory authority shall issue an order suspending the qualification or exemption from qualification of the Registrable
Securities under state securities or blue sky laws, the Company shall use its reasonable best efforts to obtain the withdrawal or lifting of such order at the earliest possible time; 
  
 (d) furnish to the selling Investor and each of the underwriter(s), if any, before filing with the Commission, copies of the
Registration Statement or any prospectus included therein or any amendments or supplements to any such Registration Statement or prospectus (including, if requested, all documents incorporated by reference after the initial filing of such
Registration Statement), and the Company will consult with the selling Investor of Registrable Securities covered by such Registration Statement or the underwriter(s), if any, prior to the filing of such Registration Statement or prospectus;

  
 (e) if requested by the selling Investor or the
underwriter(s), if any, incorporate in the Registration Statement or prospectus, pursuant to a supplement or post-effective amendment if necessary, such information as the selling Investor and underwriter(s), if any, may reasonably request to have
included therein, with respect to the number of Registrable Securities being sold to such underwriter(s), the purchase price being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such 
  

 5 

 offering and make all required filings of such prospectus supplement or post-effective amendment as soon as practicable
after the Company is notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; 
  
 (f) furnish to the selling Investor and each of the underwriter(s), if any, without charge, at least one copy of the Registration Statement, as first
filed with the Commission, and of each amendment thereto, including all documents incorporated by reference therein and all exhibits (including exhibits incorporated therein by reference); 
  
 (g) deliver to the selling Investor and each of the underwriter(s), if any,
without charge, as many copies of the prospectus (including each preliminary prospectus) and any amendment or supplement thereto as such Persons reasonably may request; the Company hereby consents to the use of the prospectus and any amendment or
supplement thereto by the selling Investor and each of the underwriter(s), if any, in connection with the offering and the sale of the Registrable Securities covered by the prospectus or any amendment or supplement thereto; 
  
 (h) prior to any public offering of Registrable Securities, the Company shall
use its reasonable best efforts to register or qualify the Registrable Securities under the securities or blue sky laws of such jurisdictions as the selling Investor or underwriter(s), if any, may reasonably request and do any and all other acts or
things reasonably necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by the Registration Statement; provided, however, that the Company shall not be required to register or
qualify as a foreign corporation where it is not now so qualified or to take any action that would subject it to the service of process in suits or to taxation, other than as to matters and transactions relating to the Registration Statement, in any
jurisdiction where it is not now so subject; 
  
 (i) cooperate
with the selling Investor and the underwriter(s), if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends; and enable such Registrable
Securities to be in such denominations and registered in such names as the Holders or the underwriter(s), if any, may request prior to any sale of Registrable Securities made by such underwriter(s); 
  
 (j) if any fact or event contemplated by clause (c)(iv) above shall
exist or have occurred, promptly prepare a supplement or post-effective amendment to the Registration Statement or related prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter
delivered to the purchasers of Registrable Securities, the prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading; 
  
 (k) cooperate and assist in any filings required to be made with the National
Association of Securities Dealers, Inc. (“NASD”) and in the performance of any due diligence investigation by any underwriter (including any “qualified independent underwriter”) that is required to be retained in
accordance with the rules and regulations of the NASD; 
  
 (l)
otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the Commission, and make generally available to its security holders, as 
  

 6 

 soon as practicable, a consolidated earnings statement meeting the requirements of the Securities Act and Rule 158
thereunder (which need not be audited) for the twelve-month period (i) commencing at the end of any fiscal quarter in which Registrable Securities are sold to underwriters in a firm or best efforts Underwritten Offering or (ii) if not sold
to underwriters in such an offering, beginning with the first month of the Company’s first fiscal quarter commencing after the effective date of the Registration Statement; 
  
 (m) enter into such customary agreements (including an underwriting agreement in form acceptable to the Company) with any
underwriter in order to expedite or facilitate the disposition of such Registrable Securities; 
  
 (n) make available for inspection by any Holder included in such Registration Statement, any underwriter participating in any disposition pursuant to such Registration Statement, and any attorney, accountant or other
agent retained by any such seller or underwriter (collectively, the “Inspectors”), all financial and other records, pertinent corporate documents and properties of the Company (collectively, the “Records”), as shall
be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such Inspector in connection with such
Registration Statement; provided that records which the Company determines, in good faith, to be confidential and which it notifies the Inspectors are confidential shall not be disclosed by the Inspectors unless (i) the disclosure of
such Records is necessary to avoid or correct a misstatement or omission in the Registration Statement or (ii) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction; provided,
further, each Holder agrees that it will, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, give notice to the Company and allow the Company, at its expense, to undertake appropriate action and to
prevent disclosure of the Records deemed confidential. 
  
 5.
Limitation on Registration; Lock-Up Agreement; Suspension of Sales. 
  
 (a) The Company is not required to file more than one Registration Statement under Section 2(a). 
  
 (b) Each Holder agrees not to effect or request any public sale or distribution of securities which are the same as or which are similar in nature as the
securities of the Company being registered, during the 14 days prior to and during the 90-day period beginning on, the effective date of a Registration Statement filed by the Company (except as part of such registration). 
  
 (c) The Company agrees not to effect or initiate a Registration Statement for
any public sale or distribution of any securities similar to those being registered, or any securities convertible into or exchangeable or exercisable for such securities, during the 14 days prior to, and during the 90-day period beginning on, the
effective date of any Registration Statement in which the Holders are participating (except as part of such registration). 
  
 (d) Each Holder agrees that, upon receipt of notice from the Company of the occurrence of any event of the kind described in
Section 4(c)(ii-iv), such Holder will forthwith 
  

 7 

 discontinue disposition of such Registrable Securities following the effective date of a Registration Statement covering
such Registrable Securities until such Holder’s receipt of copies of the prospectus supplement and/or post-effective amendment contemplated by Section 4(j), or until it is advised in writing by the Company that the use of the
applicable prospectus may be resumed and, in either case, has received copies of any additional or supplemental filings that are incorporate or deemed to be incorporated by reference in such prospectus or Registration Statement. 
  
 6. Indemnification. 
  
 (a) The Company agrees to indemnify and hold harmless the Investor and each
Person, if any, who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages, liabilities and expenses arising out of or based upon
any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or prospectus (or any amendment or supplement thereto), or arising out of or based upon any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages, liabilities or expenses arise out of or are based upon any untrue statement or omission or
alleged untrue statement or omission which has been made therein or omitted therefrom in reliance upon and in conformity with the information relating to the Investor furnished in writing to the Company by the Investor expressly for use in
connection therewith. The foregoing indemnity agreement shall be in addition to any liability which the Company may otherwise have. 
  
 (b) If any action, suit or proceeding shall be brought against the Investor or any Person controlling the Investor in respect of which indemnity may be
sought against the Company, the Investor or such controlling Person shall promptly notify the parties against whom indemnification is being sought (collectively the “Indemnifying Parties” and each an “Indemnifying
Party”), and such Indemnifying Parties shall assume the defense thereof, including the employment of counsel and payment of all fees and expenses; provided, however, that failure to so notify an Indemnifying Party shall not
relieve such Indemnifying Party from any liability unless and to the extent it is prejudiced as a result of such failure. The Investor or any such controlling Person shall have the right to employ separate counsel in any such action, suit or
proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of the Investor or such controlling Person unless (i) the Indemnifying Parties have agreed in writing to pay such fees and
expenses, (ii) the Indemnifying Parties have failed to assume the defense and employ counsel, or (iii) the named parties to any such action, suit or proceeding (including any impleaded parties) include both the Investor or such controlling
Person and the Indemnifying Parties and the Investor or such controlling Person shall have been advised in writing by its counsel that representation of such indemnified party and any Indemnifying Party by the same counsel would be inappropriate
under applicable standards of professional conduct (whether or not such representation by the same counsel has been proposed) due to actual or potential differing interests between them (in which case the Indemnifying Party shall not have the right
to assume the defense of such action, suit or proceeding on behalf of the Investor or such controlling Person). It is understood, however, that the Indemnifying Parties shall, in connection with any one such action, suit or proceeding or separate
but substantially similar or related actions, suits or proceedings in the same jurisdiction 
  

 8 

 arising out of the same general allegations or circumstances, be liable for the reasonable fees and expenses of only one
separate firm of attorneys (in addition to any local counsel) at any time for the Investor and controlling Persons not having actual or potential differing interests with the Investor or among themselves, which firm shall be designated in writing by
the Investor, and that all such fees and expenses shall be reimbursed as they are incurred. The Indemnifying Parties shall not be liable for any settlement of any such action, suit or proceeding effected without their written consent, but if settled
with such written consent, or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the Indemnifying Parties agree to indemnify and hold harmless the Investor, to the extent provided in paragraph
(a) hereof, and any such controlling Person from and against any loss, claim, damage, liability or expense by reason of such settlement or judgment. 
  
 (c) The Investor agrees to indemnify and hold harmless the Company, and its directors and officers, and any Person who controls the Company within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity from the Company to the Investor set forth in paragraph (a) hereof, but only with respect to information relating
to the Investor furnished in writing by or on behalf of the Investor expressly for use in the Registration Statement or prospectus; provided, however, that the Investor shall not be liable for any claims hereunder in an amount in
excess of the net proceeds received by the Investor from the sale of the Registrable Securities pursuant to the Registration Statement. If any action, suit or proceeding shall be brought against the Company, any of its directors or officers, or any
such controlling Person based on the Registration Statement or prospectus, and in respect of which indemnity may be sought against the Investor pursuant to this paragraph (c), the Investor shall have the rights and duties given to the Company
by paragraph (b) above (except that if the Company shall have assumed the defense thereof the Investor shall not be required to do so, but may employ separate counsel therein and participate in the defense thereof, but the fees and
expenses of such counsel shall be at the Investor’s expense), and the Company, its directors and officers, and any such controlling Person shall have the rights and duties given to the Investor by paragraph (b) above. 
  
 (d) If the indemnification provided for in this Section 6 is
unavailable (except if inapplicable according to its terms) to an indemnified party under paragraphs (a) or (c) hereof in respect of any losses, claims, damages, liabilities or expenses referred to therein, then an
Indemnifying Party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, liabilities or expenses (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company, on the one hand, and the Investor, on the other hand, from its sale of Registrable Securities (it being expressly understood and agreed that the relative benefits received by the
Company from the sale of the Registrable Securities shall be equal to the amount of net proceeds received by the Company from the sale of the Registrable Securities to the Investor), or (ii) if the allocation provided by clause
(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the
Investor, on the other hand, in connection with the statements or omissions that resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative fault of the Company, on the one
hand, and the Investor, on the other hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement 
  

 9 

 of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company, on the one hand, or by the Investor, on the other hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
  
 (e) The Company and the Investor agree that it would not be just and
equitable if contribution pursuant to this Section 6 were determined by a pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph
(d) above. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, liabilities and expenses referred to in paragraph (d) above shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating any claim or defending any such action, suit or proceeding. Notwithstanding the provisions of this Section 6, the
Investor shall not be required to contribute any amount in excess of the amount by which the net proceeds received by it in connection with the sale of the Registrable Securities exceeds the amount of any damages which the Investor has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation. 
  
 (f) The indemnity and contribution agreements contained in this Section 6 and the representations and warranties of the Company set forth in this Agreement shall remain operative and in full force and
effect, regardless of any investigation made by or on behalf of the Investor or any Person controlling the Investor, the Company, its directors or officers or any Person controlling the Company. A successor to the Investor or any Person controlling
the Investor, or to the Company, its directors or officers or any Person controlling the Company shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained in this Section 6. 
  
 (g) No Indemnifying Party shall, without the prior written consent of the
indemnified party, effect any settlement of any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless
such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding. 
  
 7. Rule 144 Requirements. The Company is subject to the reporting requirements of the Exchange Act and the
Company will use its reasonable best efforts to file with the Commission such information as the Commission may require and will use its reasonable best efforts to make available Rule 144 under the Securities Act (or any successor exemptive rule).

  
 8. Obligations of the Investor and Others in a
Registration. The Investor agrees to timely furnish such information regarding such Person and the securities sought to be registered and to take such other action as the Company may reasonably request in connection with the registration,
qualification or compliance. The Company may exclude from any Registration Statement the Investor if it fails to timely comply with the provisions of the 
  

 10 

 preceding sentence. If the registration involves an underwriter, the Investor agrees, upon the request of such
underwriter, not to sell any unregistered securities of the Company for a period of ninety (90) days following the effective date of the Registration Statement for such offering and to enter into an underwriting agreement with such underwriters
containing usual and customary terms and provisions. The Investor agrees not to affect the sale of securities under any Registration Statement until it has received a prospectus, as needed, and notice of the effectiveness of the Registration
Statement of which the prospectus forms a part. 
  
 9.
Preparation; Reasonable Investigation. In connection with the preparation and filing of each Registration Statement under the Securities Act pursuant to this Agreement, the Company will give the Holders, their underwriters, if any, and
one counsel or firm of counsel and one accountant or firm of accountants representing all the Holders, the opportunity to participate in the preparation of such Registration Statement, each prospectus included therein or filed with the Commission,
and each amendment thereof or supplement thereto. 
  
 10.
Rule 144A. The Company agrees that, upon the request of any Holder or any prospective purchaser of Registrable Securities designated by a Holder, the Company shall promptly provide (but in any case within 15 days of a request) to such
Holder or potential purchaser, the following information: 
  
 (a)
a brief statement of the nature of the business of the Company and any subsidiaries and the products and services they offer; 
  
 (b) the most recent consolidated balance sheets and profit and losses and retained earnings statements, and similar financial statements of the Company
for the two (2) most recent fiscal years (such financial information shall be audited, to the extent reasonably available); and 
  
 (c) such other information about the Company, any subsidiaries, and their business, financial condition and results of operations as the requesting Holder
or purchaser of such Registrable Securities shall request in order to comply with Rule 144A, as amended, and in connection therewith the anti-fraud provisions of the federal and state securities laws. 
  
 The Company hereby represents and warrants to any such requesting Holder and
any prospective purchaser of Registrable Securities from such Holder that the information provided by the Company pursuant to this Section 10 will, as of their dates, not contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading. 
  
 11. Consent to be Bound. Each subsequent Holder must consent in writing to be bound by the terms and conditions of this Agreement in order
to acquire the rights granted pursuant to this Agreement. 
  
 12.
Assignability of Registration Rights. Subject to Section 11 hereof and Section 4.1 of the Purchase Agreement, the registration rights set forth in this Agreement are assignable to each assignee as to each share of
Registrable Securities conveyed in accordance herewith who agrees in writing to be bound by the terms and conditions of this Agreement. 
  

 11 

 13. Amendment, Termination and Waiver. Except as otherwise provided herein, no amendment,
modification, termination or cancellation of this Agreement shall be effective unless made in a writing signed by the Company and the Investor. 
  
 14. Specific Performance. The Company and the Investor agree that the rights created by this Agreement are unique, and that the loss of any
such right is not susceptible to monetary quantification. Consequently, the parties agree that an action for specific performance (including for temporary and/or permanent injunctive relief) of the obligations created by this Agreement is a proper
remedy for the breach of the provisions of this Agreement, without the necessity of proving actual damages. If the parties hereto are forced to institute legal proceedings to enforce their rights in accordance with the provisions of this Agreement,
the prevailing party shall be entitled to recover its reasonable expenses, including attorneys’ fees, in connection with any such action. 
  
 15. Miscellaneous. 
  
 (a) Except as otherwise specifically provided herein, all notices, requests, demands and other communications provided for hereunder shall be in writing
and shall be deemed effectively given (i) upon receipt when personally delivered, (ii) one (1) day after being sent by overnight delivery or telecopy providing confirmation or receipt of delivery, or (iii) three (3) days
after being sent by certified or registered mail, postage and charges prepaid, return receipt requested, to the applicable party at the addresses indicated below: 
  
 If to the Company: 
  
 eMerge Interactive, Inc. 
 10305 102nd Terrace

 Sebastian, Florida 32958 
 Attention: David C. Warren 
  
 Telephone:
(772) 581-9741 
 Telecopy:   (772) 581-0204 
  
 With a copy to: 
  
 Hunton & Williams LLP 
 Riverfront
Plaza, East Tower 
 951 East Byrd Street 
 Richmond, VA 23219 
 Attention: Gary Thompson 
 Telephone: (804) 788-8200 
 Telecopy:   (804) 788-8218 
  

 12 

 If to the Investor: 
  
 Judith Ackland and Larry Cox, Co-Trustees of 
 The Biegert Family Irrevocable Trust 
 Biegert Feeds 
 115 So. 14th Street 
 Geneva, NE 68361

 Attention:   Jeff Biegert 
 Telephone: (402) 759-4994 
 Telecopy:   (402) 759-4995 
  
 With a copy to: 
  
 or, as to each of the foregoing, at such other address as shall be designated by such Person
in a written notice to the other parties complying as to delivery with the terms of this paragraph (a). 
  
 (b) This Agreement and the legal relations between the parties arising hereunder shall be governed by and interpreted in accordance with the laws of the
State of Delaware without regard to the principles of conflicts of law thereof. 
  
 (c) This Agreement and the Purchase Agreement, and all other agreements executed in connection herewith and therewith, constitute the full and entire understanding and agreement between the parties regarding the
matters set forth herein and therein. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon the successors, assigns, heirs, executors and administrators of the parties. 
  
 (d) This Agreement may be executed in any number of counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 (e) If any provision of this Agreement shall be held to be illegal, invalid or unenforceable, such illegality, invalidity or unenforceability shall attach
only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable any other provision of this Agreement, and this Agreement shall be carried out as if any such illegal, invalid or unenforceable provision were not
contained herein. 
  
 [Remainder of page left blank
intentionally; signature page follows] 
  

 13 

 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly executed
as of the date first set forth above. 
  

			
	THE COMPANY:
	eMerge Interactive, Inc.
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

	
	THE INVESTOR:
	Judith Ackland and Larry Cox, Co-Trustees of
	The Biegert Family Irrevocable Trust
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

  
 [Signature page
for Registration Rights Agreement] 
  

 14 

 Exhibit B 
  
 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. 
  
 ISSUE DATE: January     , 2006 
  
 COMMON STOCK PURCHASE WARRANT 
  

To Purchase 5,000,000 Shares of Common Stock of 
  
 eMerge Interactive, Inc. 
  
 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, for value received, The Biegert Family Irrevocable Trust, dated June
11, 1998 (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July     , 2006 (the “Initial
Exercise Date”) and on or prior to the close of business on July     , 2011 (the “Termination Date”) but not thereafter, to subscribe for and purchase from eMerge Interactive Inc., a corporation
incorporated in Delaware (the “Company”), up to 5,000,000 shares (the “Warrant Shares”) of Common Stock, par value $0.008 per share, of the Company (the “Common Stock”). The purchase price of one
share of Common Stock (the “Exercise Price”) under this Warrant shall be [$            ] [110% of the Closing Price of the Common Stock of the Company as of the
Trading Day immediately preceding the date of issuance], subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms
used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Purchase Agreement”), dated as of [January     , 2006], between the Company and
Holder. 
  
 1. Authorization of Warrant Shares. The Company
represents and warrants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). 

 2. Exercise of Warrant. 
  
 (a) Except as otherwise provided herein, exercise of the purchase rights represented by this Warrant may be made at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by the surrender of this Warrant and the Notice of Exercise Form annexed hereto duly executed, at the office of the Company (or such other office or agency of the
Company as it may designate by notice in writing to the registered Holder at the address of such Holder appearing on the books of the Company) and upon payment of the Exercise Price of the shares thereby purchased by wire transfer or cashier’s
check drawn on a United States bank, the Holder shall be entitled to receive a certificate for the number of Warrant Shares so purchased. Certificates for shares purchased hereunder shall be delivered to the Holder promptly thereafter. This Warrant
shall be deemed to have been exercised and such certificate or certificates shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for
all purposes, as of the date the Warrant has been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant to Section 4 prior to the issuance of such shares, have been paid. If the
Company fails to deliver to the Holder a certificate or certificates representing the Warrant Shares pursuant to an exercise by the tenth Trading Day after the date of exercise, and if after such tenth Trading Day the Holder is required by its
broker to purchase (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”),
then the Company shall (1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying
(A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (B) the price at which the sell order giving rise to such purchase obligation was executed, and (2) at the option
of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company
timely complied with its exercise and delivery obligations hereunder. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In, together with applicable confirmations and other
evidence reasonably requested by the Company. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof. 
  
 (b) If this Warrant shall have been exercised in part, the Company shall, at
the time of delivery of the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant. 

 3. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant, and, in lieu thereof, such fraction shall be rounded down to the nearest whole share. 
  
 4. Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
duly executed by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. 
  
 5. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the
timely exercise of this Warrant, pursuant to the terms hereof. 
  
 6. Transfer, Division and Combination. 
  
 (a)
Subject to compliance with any applicable securities laws and the conditions set forth herein and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender
of this Warrant at the principal office of the Company, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes
payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denomination or denominations specified
in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be exercised by a new holder
for the purchase of Warrant Shares without having a new Warrant issued.  
  
 (b) This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new
Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 6(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. 
  
 (c) The Company shall prepare, issue and deliver at its own expense (other than transfer taxes) the new Warrant or Warrants under this Section 6.

  
 (d) The Company agrees to maintain, at its aforesaid office,
books for the registration and the registration of transfer of the Warrants. 
  
 (e) If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be registered pursuant to an 

 effective registration statement under the Securities Act and under applicable state securities or blue sky laws, the
Company may require, as a condition of allowing such transfer (i) that the Holder or transferee of this Warrant, as the case may be, furnish to the Company a written opinion of counsel (which opinion shall be in form, substance and scope customary
for opinions of counsel in comparable transactions) to the effect that such transfer may be made without registration under the Securities Act and under applicable state securities or blue sky laws, (ii) that the holder or transferee execute and
deliver to the Company an investment letter in form and substance acceptable to the Company and (iii) that the transferee be an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or (a)(8) promulgated under the
Securities Act or a qualified institutional buyer as defined in Rule 144A(a) under the Securities Act. 
  
 7. No Rights as Shareholder until Exercise. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder of the
Company prior to the exercise hereof. Upon the surrender of this Warrant and the payment of the aggregate Exercise Price, the Warrant Shares so purchased shall be and be deemed to be issued to such Holder as the record owner of such shares as of the
close of business on the later of the date of such surrender or payment. 
  
 8. Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and
upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

  
 9. Saturdays, Sundays, Holidays, etc. If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday, Sunday or a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day not a
Saturday, Sunday or legal holiday. 
  
 10. Adjustments of
Exercise Price and Number of Warrant Shares. 
  
 (a) Stock
Splits, etc. The number and kind of securities purchasable upon the exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time upon the happening of any of the following. In case the Company shall (i) pay a
dividend in shares of Common Stock or make a distribution in shares of Common Stock to holders of its outstanding Common Stock, (ii) subdivide its outstanding shares of Common Stock into a greater number of shares, (iii) combine its outstanding
shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issue any shares of its capital stock in a reclassification of the Common Stock, then the number of Warrant Shares purchasable upon exercise of this Warrant immediately
prior thereto shall be adjusted so that the Holder shall be entitled to receive the kind and number of Warrant Shares or other securities of the Company which it would have owned or have been entitled to receive had such Warrant been exercised in
advance thereof. Upon each such adjustment of the kind and number of Warrant Shares or other securities of the Company which are purchasable hereunder, the Holder shall thereafter be entitled to purchase the number of Warrant Shares or other
securities resulting from such adjustment at an Exercise Price 

 per Warrant Share or other security obtained by multiplying the Exercise Price in effect immediately prior to such
adjustment by the number of Warrant Shares purchasable pursuant hereto immediately prior to such adjustment and dividing by the number of Warrant Shares or other securities of the Company resulting from such adjustment. An adjustment made pursuant
to this paragraph shall become effective immediately after the effective date of such event retroactive to the record date, if any, for such event. 
  
 (b) Anti–Dilution Provisions. During the Exercise Period, the Exercise Price for which this Warrant is then exercisable shall be subject to
adjustment from time to time as provided in this Section 10(b). In the event that any adjustment of the Exercise Price as required herein results in a fraction of a cent, such Exercise Price shall be rounded down to the nearest cent. 
  
 (i) Adjustment of Exercise Price. If and whenever the Company issues
or sells, or in accordance with Section 10(b) hereof is deemed to have issued or sold, any shares of Common Stock for an effective consideration per share of less than the then Exercise Price or for no consideration (such lower price, the
“Base Share Price” and such issuances collectively, a “Dilutive Issuance”), then, the Exercise Price shall be reduced to a price equal to the Base Share Price (the “Adjusted Exercise Price”). Such
adjustment shall be made whenever such shares of Common Stock or Common Stock Equivalents are issued. 
  
 (ii) Effect on Exercise Price of Certain Events. For purposes of determining the Adjusted Exercise Price under Section 10(b) hereof, the following
will be applicable: 
  
 (A) Issuance of Rights or
Options. If the Company in any manner issues or grants any warrants, rights or options, whether or not immediately exercisable, to subscribe for or to purchase Common Stock or Common Stock Equivalents (such warrants, rights and options to
purchase Common Stock or Common Stock Equivalents are hereinafter referred to as “Options”) and the effective price per share for which Common Stock is issuable upon the exercise of such Options is less than the Exercise Price
(“Below Base Price Options”), then the maximum total number of shares of Common Stock issuable upon the exercise of all such Below Base Price Options (assuming full exercise, conversion or exchange of Common Stock Equivalents, if
applicable) will, as of the date of the issuance or grant of such Below Base Price Options, be deemed to be outstanding and to have been issued and sold by the Company for such price per share and the maximum consideration payable to the Company
upon such exercise (assuming full exercise, conversion or exchange of Common Stock Equivalents, if applicable) will be deemed to have been received by the Company. For purposes of the preceding sentence, the “effective price per share for which
Common Stock is issuable upon the exercise of such Below Base Price Options” is determined by dividing (i) the total amount, if any, received or receivable by the Company as consideration for the issuance or granting of all such Below Base
Price Options, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise of all such Below Base Price Options, plus, in the case of Common Stock Equivalents issuable upon the exercise of such
Below Base Price Options, the minimum aggregate amount of additional consideration payable upon the exercise, conversion or exchange thereof at the time such Common Stock Equivalents first become exercisable, convertible or exchangeable, by (ii) the
maximum total number of shares of 

 Common Stock issuable upon the exercise of all such Below Base Price Options (assuming full conversion of Common Stock
Equivalents, if applicable). No further adjustment to the Exercise Price will be made upon the actual issuance of such Common Stock upon the exercise of such Below Base Price Options or upon the exercise, conversion or exchange of Common Stock
Equivalents issuable upon exercise of such Below Base Price Options. 
  
 (B) Issuance of Common Stock Equivalents. If the Company in any manner issues or sells any Common Stock Equivalents, whether or not immediately convertible (other than where the same are issuable upon the exercise of Options) and the
effective price per share for which Common Stock is issuable upon such exercise, conversion or exchange is less than the Exercise Price, then the maximum total number of shares of Common Stock issuable upon the exercise, conversion or exchange of
all such Common Stock Equivalents will, as of the date of the issuance of such Common Stock Equivalents, be deemed to be outstanding and to have been issued and sold by the Company for such price per share and the maximum consideration payable to
the Company upon such exercise (assuming full exercise, conversion or exchange of Common Stock Equivalents, if applicable) will be deemed to have been received by the Company. For the purposes of the preceding sentence, the “effective price per
share for which Common Stock is issuable upon such exercise, conversion or exchange” is determined by dividing (i) the total amount, if any, received or receivable by the Company as consideration for the issuance or sale of all such Common
Stock Equivalents, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise, conversion or exchange thereof at the time such Common Stock Equivalents first become exercisable, convertible or
exchangeable, by (ii) the maximum total number of shares of Common Stock issuable upon the exercise, conversion or exchange of all such Common Stock Equivalents. No further adjustment to the Exercise Price will be made upon the actual issuance of
such Common Stock upon exercise, conversion or exchange of such Common Stock Equivalents. 
  
 (C) Change in Option Price or Conversion Rate. If there is a change at any time in (i) the amount of additional consideration payable to the Company upon the exercise of any Options; (ii) the amount of
additional consideration, if any, payable to the Company upon the exercise, conversion or exchange of any Common Stock Equivalents; or (iii) the rate at which any Common Stock Equivalents are convertible into or exchangeable for Common Stock (in
each such case, other than under or by reason of provisions designed to protect against dilution), the Exercise Price in effect at the time of such change will be readjusted to the Exercise Price which would have been in effect at such time had such
Options or Common Stock Equivalents still outstanding provided for such changed additional consideration or changed conversion rate, as the case may be, at the time initially granted, issued or sold. 
  
 (D) Calculation of Consideration Received. If any Common Stock,
Options or Common Stock Equivalents are issued, granted or sold for cash, the consideration received therefor for purposes of this Warrant will be the amount received by the Company therefor, before deduction of reasonable commissions, underwriting
discounts or allowances or other reasonable expenses paid or incurred by the Company in connection with such issuance, grant or sale. In case any Common Stock, Options or Common Stock Equivalents are issued or sold for a consideration part or all of
which shall be other than cash, the amount of the consideration other than cash received by the Company will be the fair market value of such 

 consideration, except where such consideration consists of securities, in which case the amount of consideration received
by the Company will be the fair market value (closing bid price, if traded on any market) thereof as of the date of receipt. In case any Common Stock, Options or Common Stock Equivalents are issued in connection with any merger or consolidation in
which the Company is the surviving corporation, the amount of consideration therefor will be deemed to be the fair market value of such portion of the net assets and business of the non-surviving corporation as is attributable to such Common Stock,
Options or Common Stock Equivalents, as the case may be. The fair market value of any consideration other than cash or securities will be determined in good faith by the Company’s Board of Directors. 
  
 (E) Exceptions to Adjustment of Exercise Price. Notwithstanding the
foregoing, no adjustment will be made under this Section 10(b) in respect of the issuance of (1) shares of Common Stock or options to employees, consultants, advisors, officers or directors of the Company pursuant to any stock or option plan duly
adopted by the Board of Directors of the Company or a committee established for such purpose, (2) securities upon the exercise of or conversion of any convertible securities, options or warrants issued and outstanding on the Original Issue Date, (3)
securities in connection with acquisitions or strategic investments (including, without limitation, any licensing or distribution arrangements), the primary purpose of which is not to raise capital, (4) securities to financial institutions or
lessors in connection with commercial credit arrangements, equipment financings or similar transactions, where the principal consideration for such transaction is not the issuance of such securities, or (5) in a transaction described in Section
10(a) or 11. 
  
 (F) Minimum Adjustment of Exercise Price.
No adjustment of the Exercise Price shall be made in an amount of less than 1% of the Exercise Price in effect at the time such adjustment is otherwise required to be made, but any such lesser adjustment shall be carried forward and shall be made at
the time and together with the next subsequent adjustment which, together with any adjustments so carried forward, shall amount to not less than 1% of such Exercise Price. 
  
 11. Reorganization, Reclassification, Merger, Consolidation or Disposition of Assets. In case the Company shall
reorganize its capital, reclassify its capital stock, consolidate or merge with or into another corporation (where the Company is not the surviving corporation or where there is a change in or distribution with respect to the Common Stock of the
Company), or sell, transfer or otherwise dispose of all or substantially all its property, assets or business to another corporation and, pursuant to the terms of such reorganization, reclassification, merger, consolidation or disposition of assets,
shares of common stock of the successor or acquiring corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu of common
stock of the successor or acquiring corporation (“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then the Holder shall have the right thereafter to receive, at the option of the
Company, (a) upon exercise of this Warrant, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable upon or as a result of such
reorganization, reclassification, merger, consolidation or disposition of assets by a Holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event or (b) cash equal to the value of this Warrant
as determined in accordance with the 

 Black-Scholes option pricing formula. In case of any such reorganization, reclassification, merger, consolidation or
disposition of assets, the successor or acquiring corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Warrant to be performed and observed by
the Company and all the obligations and liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of
Warrant Shares for which this Warrant is exercisable which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 11. For purposes of this Section 11, “common stock of the successor or acquiring
corporation” shall include stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption and shall also include any evidences of
indebtedness, shares of stock or other securities which are convertible into or exchangeable for any such stock, either immediately or upon the arrival of a specified date or the happening of a specified event and any warrants or other rights to
subscribe for or purchase any such stock. The foregoing provisions of this Section 11 shall similarly apply to successive reorganizations, reclassifications, mergers, consolidations or disposition of assets. 
  
 12. Voluntary Adjustment by the Company. The Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company. 
  
 13. Notice of Adjustment. Whenever the number of Warrant Shares or number or kind of securities or other property
purchasable upon the exercise of this Warrant or the Exercise Price is adjusted, as herein provided, the Company shall give notice thereof to the Holder, which notice shall state the number of Warrant Shares (and other securities or property)
purchasable upon the exercise of this Warrant and the Exercise Price of such Warrant Shares (and other securities or property) after such adjustment, setting forth a brief statement of the facts requiring such adjustment and setting forth the
computation by which such adjustment was made. 
  
 14. Notice
of Corporate Action. If at any time: 
  
 (a) the Company
shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or other distribution, or any right to subscribe for or purchase any evidences of its indebtedness, any shares of stock of any class or
any other securities or property, or to receive any other right, or 
  
 (b) there shall be any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any consolidation or merger of the Company with, or any sale, transfer or other disposition of all
or substantially all the property, assets or business of the Company to, another corporation or, 
  
 (c) there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company; 
  
 then, in any one or more of such cases, the Company shall give to Holder (i)
at least 10 days’ prior written notice of the date on which a record date shall be selected for such 

 dividend, distribution or right or for determining rights to vote in respect of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition, liquidation or winding up, and (ii) in the case of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or
winding up, at least 10 days’ prior written notice of the date when the same shall take place. Such notice in accordance with the foregoing clause also shall specify (i) the date on which any such record is to be taken for the purpose of such
dividend, distribution or right, the date on which the holders of Common Stock shall be entitled to any such dividend, distribution or right, and the amount and character thereof, and (ii) the date on which any such reorganization, reclassification,
merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to take place and the time, if any such time is to be fixed, as of which the holders of Common Stock shall be entitled to exchange their Warrant Shares for
securities or other property deliverable upon such disposition, dissolution, liquidation or winding up. Each such written notice shall be sufficiently given if addressed to Holder at the last address of Holder appearing on the books of the Company
and delivered in accordance with Section 16(d). Failure to provide such notice or any defect therein shall not affect the legality or validity of such action. 
  

15. Authorized Shares; Other Matters. The Company covenants that during the period the Warrant is outstanding, it will reserve from its
authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. Except and to the extent as waived or consented to by the Holder, the
Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against impairment. 
  
 16. Miscellaneous. 
  
 (a)
Jurisdiction. This Warrant shall constitute a contract under the laws of Delaware, without regard to its conflict of law, principles or rules. 
  
 (b) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have
restrictions upon resale imposed by state and federal securities laws. 
  
 (c) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder’s rights, powers or remedies,
notwithstanding all rights hereunder terminate on the Termination Date. 
  
 (d) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement. 

 (e) Limitation of Liability. No provision hereof, in the absence of any affirmative action by
Holder to exercise this Warrant or purchase Warrant Shares, and no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company,
whether such liability is asserted by the Company or by creditors of the Company. 
  
 (f) Remedies. Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company
agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive the defense in any action for specific performance that a remedy at law
would be adequate. 
  
 (g) Successors and Assigns. Subject
to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions of this
Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by any such Holder or holder of Warrant Shares. 
  
 (h) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of
the Company and the Holder. 
  
 (i) Severability. Wherever
possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant. 
  

(j) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant. 
  
 [Signature Page Follows.] 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized.

  
 Dated: January     , 2006 
  

			
	eMERGE INTERACTIVE INC.
		
	By:	 	  

	Name:	 	 
	Title:	 	 

 NOTICE OF EXERCISE 
  
 To:      eMerge Interactive Inc. 
  
 (1) The undersigned hereby elects to purchase
                 Warrant Shares of eMerge Interactive Inc. pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment
of the exercise price in full, together with all applicable transfer taxes, if any. 
  
 (2) Payment shall be in lawful money of the United States. 
  
 (3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below: 
  
                                       
                                       
  
 The Warrant Shares shall be delivered to the following: 
  
                                       
                                       
  
                                       
                                       
  
                                       
                                       
  
 (4) Accredited Investor/Qualified Institutional Buyer. The undersigned
is either: (i) an “accredited investor” as defined in Regulation D under the Securities Act of 1933, as amended. 
  

			
	[PURCHASER]
		
	By:	 	

	Name:	 	 
	Title:	 	 
	
	Dated:
                                    

  
 ASSIGNMENT
FORM 
  
 (To assign the foregoing warrant, execute 

this form and supply required information. 
 Do not use this form to exercise the warrant.) 

 FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

  
                                       
                                        
               whose address is 
  
                                       
                                        
                                        
                          . 
  

                                      
                                        
                                        
                           
  

Dated:
                            ,
             
  

			
	Holder’s Signature:	  	  

		
	Holder’s Address:	  	  

		
	 	  	  

  
 Signature Guaranteed:
                                        
                                        
                     
  
 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]